id	sid	tid	token	lemma	pos
work_4ezbiswdwvaltiifn3v3mawqzu	1	1	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	1	2	Increasing	increase	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	1	3	Importance	importance	NN
work_4ezbiswdwvaltiifn3v3mawqzu	1	4	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	1	5	Systematic	Systematic	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	1	6	Reviews	Reviews	NNPS
work_4ezbiswdwvaltiifn3v3mawqzu	1	7	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	1	8	Clinical	Clinical	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	1	9	Dermatology	Dermatology	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	1	10	Research	Research	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	1	11	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	1	12	Publication	Publication	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	1	13	EDITORIAL	EDITORIAL	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	1	14	©	©	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	1	15	2006	2006	CD
work_4ezbiswdwvaltiifn3v3mawqzu	1	16	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	1	17	Society	Society	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	1	18	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	1	19	Investigative	Investigative	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	1	20	Dermatology	Dermatology	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	1	21	www.jidonline.org	www.jidonline.org	NN
work_4ezbiswdwvaltiifn3v3mawqzu	1	22	2357	2357	CD
work_4ezbiswdwvaltiifn3v3mawqzu	1	23	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	1	24	Increasing	increase	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	1	25	Importance	importance	NN
work_4ezbiswdwvaltiifn3v3mawqzu	1	26	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	1	27	Systematic	Systematic	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	1	28	Reviews	Reviews	NNPS
work_4ezbiswdwvaltiifn3v3mawqzu	1	29	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	1	30	Clinical	Clinical	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	1	31	Dermatology	Dermatology	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	1	32	Research	Research	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	1	33	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	1	34	Publication	Publication	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	1	35	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	1	36	number	number	NN
work_4ezbiswdwvaltiifn3v3mawqzu	1	37	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	1	38	published	publish	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	1	39	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	1	40	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	1	41	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	1	42	growing	grow	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	1	43	rapidly	rapidly	RB
work_4ezbiswdwvaltiifn3v3mawqzu	1	44	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	1	45	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	1	46	such	such	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	1	47	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	1	48	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	1	49	receiving	receive	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	1	50	increased	increase	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	1	51	attention	attention	NN
work_4ezbiswdwvaltiifn3v3mawqzu	1	52	from	from	IN
work_4ezbiswdwvaltiifn3v3mawqzu	1	53	sci-	sci-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	1	54	entists	entist	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	1	55	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	1	56	editors	editor	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	1	57	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	1	58	policy	policy	NN
work_4ezbiswdwvaltiifn3v3mawqzu	1	59	makers	maker	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	1	60	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	1	61	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	1	62	consumers	consumer	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	1	63	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	2	1	Unlike	unlike	IN
work_4ezbiswdwvaltiifn3v3mawqzu	2	2	most	most	JJS
work_4ezbiswdwvaltiifn3v3mawqzu	2	3	traditional	traditional	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	2	4	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	2	5	articles	article	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	2	6	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	2	7	quality	quality	NN
work_4ezbiswdwvaltiifn3v3mawqzu	2	8	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	2	9	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	2	10	use	use	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	2	11	an	an	DT
work_4ezbiswdwvaltiifn3v3mawqzu	2	12	explicit	explicit	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	2	13	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	2	14	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	2	15	predefined	predefine	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	2	16	methodology	methodology	NN
work_4ezbiswdwvaltiifn3v3mawqzu	2	17	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	2	18	minimize	minimize	VB
work_4ezbiswdwvaltiifn3v3mawqzu	2	19	bias	bias	NN
work_4ezbiswdwvaltiifn3v3mawqzu	2	20	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	2	21	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	2	22	increase	increase	VB
work_4ezbiswdwvaltiifn3v3mawqzu	2	23	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	2	24	precision	precision	NN
work_4ezbiswdwvaltiifn3v3mawqzu	2	25	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	2	26	measurements	measurement	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	2	27	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	2	28	treatment	treatment	NN
work_4ezbiswdwvaltiifn3v3mawqzu	2	29	effects	effect	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	2	30	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	3	1	Yet	yet	CC
work_4ezbiswdwvaltiifn3v3mawqzu	3	2	methodological	methodological	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	3	3	flaws	flaw	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	3	4	can	can	MD
work_4ezbiswdwvaltiifn3v3mawqzu	3	5	exist	exist	VB
work_4ezbiswdwvaltiifn3v3mawqzu	3	6	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	3	7	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	3	8	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	3	9	that	that	WDT
work_4ezbiswdwvaltiifn3v3mawqzu	3	10	limit	limit	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	3	11	their	-PRON-	PRP$
work_4ezbiswdwvaltiifn3v3mawqzu	3	12	utility	utility	NN
work_4ezbiswdwvaltiifn3v3mawqzu	3	13	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	4	1	To	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	4	2	reduce	reduce	VB
work_4ezbiswdwvaltiifn3v3mawqzu	4	3	unnecessary	unnecessary	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	4	4	duplication	duplication	NN
work_4ezbiswdwvaltiifn3v3mawqzu	4	5	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	4	6	clinical	clinical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	4	7	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	4	8	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	4	9	ensure	ensure	VB
work_4ezbiswdwvaltiifn3v3mawqzu	4	10	that	that	IN
work_4ezbiswdwvaltiifn3v3mawqzu	4	11	scarce	scarce	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	4	12	resources	resource	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	4	13	address	address	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	4	14	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	4	15	most	most	RBS
work_4ezbiswdwvaltiifn3v3mawqzu	4	16	pressing	pressing	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	4	17	research	research	NN
work_4ezbiswdwvaltiifn3v3mawqzu	4	18	needs	need	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	4	19	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	4	20	institutional	institutional	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	4	21	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	4	22	board	board	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	4	23	panels	panel	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	4	24	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	4	25	dermatology	dermatology	NN
work_4ezbiswdwvaltiifn3v3mawqzu	4	26	journals	journal	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	4	27	should	should	MD
work_4ezbiswdwvaltiifn3v3mawqzu	4	28	consider	consider	VB
work_4ezbiswdwvaltiifn3v3mawqzu	4	29	requiring	require	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	4	30	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	4	31	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	4	32	or	or	CC
work_4ezbiswdwvaltiifn3v3mawqzu	4	33	reference	reference	NN
work_4ezbiswdwvaltiifn3v3mawqzu	4	34	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	4	35	existing	exist	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	4	36	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	4	37	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	4	38	as	as	IN
work_4ezbiswdwvaltiifn3v3mawqzu	4	39	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	4	40	pre-	pre-	NN
work_4ezbiswdwvaltiifn3v3mawqzu	4	41	requisite	requisite	NN
work_4ezbiswdwvaltiifn3v3mawqzu	4	42	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	4	43	protocol	protocol	NN
work_4ezbiswdwvaltiifn3v3mawqzu	4	44	approval	approval	NN
work_4ezbiswdwvaltiifn3v3mawqzu	4	45	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	4	46	publication	publication	NN
work_4ezbiswdwvaltiifn3v3mawqzu	4	47	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	4	48	clinical	clinical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	4	49	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	4	50	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	5	1	What	what	WP
work_4ezbiswdwvaltiifn3v3mawqzu	5	2	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	5	3	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	5	4	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	5	5	?	?	.
work_4ezbiswdwvaltiifn3v3mawqzu	6	1	Systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	6	2	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	6	3	differ	differ	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	6	4	from	from	IN
work_4ezbiswdwvaltiifn3v3mawqzu	6	5	traditional	traditional	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	6	6	narrative	narrative	NN
work_4ezbiswdwvaltiifn3v3mawqzu	6	7	expert-	expert-	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	6	8	opinion	opinion	NN
work_4ezbiswdwvaltiifn3v3mawqzu	6	9	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	6	10	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	6	11	their	-PRON-	PRP$
work_4ezbiswdwvaltiifn3v3mawqzu	6	12	comprehensive	comprehensive	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	6	13	sys-	sys-	NN
work_4ezbiswdwvaltiifn3v3mawqzu	6	14	tematic	tematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	6	15	approach	approach	NN
work_4ezbiswdwvaltiifn3v3mawqzu	6	16	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	6	17	summarizing	summarize	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	6	18	health	health	NN
work_4ezbiswdwvaltiifn3v3mawqzu	6	19	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	6	20	care	care	NN
work_4ezbiswdwvaltiifn3v3mawqzu	6	21	evidence	evidence	NN
work_4ezbiswdwvaltiifn3v3mawqzu	6	22	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	6	23	Levin	Levin	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	6	24	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	6	25	2001	2001	CD
work_4ezbiswdwvaltiifn3v3mawqzu	6	26	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	6	27	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	6	28	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	6	29	now	now	RB
work_4ezbiswdwvaltiifn3v3mawqzu	6	30	required	require	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	6	31	by	by	IN
work_4ezbiswdwvaltiifn3v3mawqzu	6	32	some	some	DT
work_4ezbiswdwvaltiifn3v3mawqzu	6	33	biomedical	biomedical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	6	34	journals	journal	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	6	35	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	6	36	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	6	37	example	example	NN
work_4ezbiswdwvaltiifn3v3mawqzu	6	38	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	6	39	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	6	40	Lancet	Lancet	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	6	41	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	6	42	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	6	43	clinical	clinical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	6	44	trial	trial	NN
work_4ezbiswdwvaltiifn3v3mawqzu	6	45	publication	publication	NN
work_4ezbiswdwvaltiifn3v3mawqzu	6	46	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	6	47	Young	Young	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	6	48	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	6	49	Horton	Horton	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	6	50	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	6	51	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	6	52	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	6	53	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	7	1	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	7	2	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	7	3	approach	approach	NN
work_4ezbiswdwvaltiifn3v3mawqzu	7	4	starts	start	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	7	5	with	with	IN
work_4ezbiswdwvaltiifn3v3mawqzu	7	6	formulation	formulation	NN
work_4ezbiswdwvaltiifn3v3mawqzu	7	7	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	7	8	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	7	9	clear	clear	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	7	10	question	question	NN
work_4ezbiswdwvaltiifn3v3mawqzu	7	11	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	7	12	followed	follow	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	7	13	by	by	IN
work_4ezbiswdwvaltiifn3v3mawqzu	7	14	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	7	15	thorough	thorough	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	7	16	search	search	NN
work_4ezbiswdwvaltiifn3v3mawqzu	7	17	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	7	18	all	all	DT
work_4ezbiswdwvaltiifn3v3mawqzu	7	19	relevant	relevant	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	7	20	evidence	evidence	NN
work_4ezbiswdwvaltiifn3v3mawqzu	7	21	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	7	22	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	7	23	critical	critical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	7	24	appraisal	appraisal	NN
work_4ezbiswdwvaltiifn3v3mawqzu	7	25	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	7	26	that	that	DT
work_4ezbiswdwvaltiifn3v3mawqzu	7	27	evidence	evidence	NN
work_4ezbiswdwvaltiifn3v3mawqzu	7	28	using	use	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	7	29	predeter-	predeter-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	7	30	mined	mined	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	7	31	criteria	criterion	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	7	32	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	7	33	quantitative	quantitative	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	7	34	pooling	pooling	NN
work_4ezbiswdwvaltiifn3v3mawqzu	7	35	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	7	36	metaanaly-	metaanaly-	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	7	37	sis	sis	NN
work_4ezbiswdwvaltiifn3v3mawqzu	7	38	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	7	39	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	7	40	similar	similar	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	7	41	study	study	NN
work_4ezbiswdwvaltiifn3v3mawqzu	7	42	results	result	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	7	43	when	when	WRB
work_4ezbiswdwvaltiifn3v3mawqzu	7	44	appropriate	appropriate	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	7	45	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	7	46	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	7	47	finally	finally	RB
work_4ezbiswdwvaltiifn3v3mawqzu	7	48	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	7	49	interpretation	interpretation	NN
work_4ezbiswdwvaltiifn3v3mawqzu	7	50	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	7	51	that	that	DT
work_4ezbiswdwvaltiifn3v3mawqzu	7	52	evidence	evidence	NN
work_4ezbiswdwvaltiifn3v3mawqzu	7	53	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	7	54	Bigby	Bigby	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	7	55	et	et	FW
work_4ezbiswdwvaltiifn3v3mawqzu	7	56	al	al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	7	57	.	.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	7	58	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	7	59	2003	2003	CD
work_4ezbiswdwvaltiifn3v3mawqzu	7	60	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	7	61	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	8	1	Authors	author	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	8	2	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	8	3	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	8	4	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	8	5	con-	con-	NN
work_4ezbiswdwvaltiifn3v3mawqzu	8	6	ducted	ducte	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	8	7	within	within	IN
work_4ezbiswdwvaltiifn3v3mawqzu	8	8	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	8	9	Cochrane	Cochrane	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	8	10	Collaboration	Collaboration	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	8	11	make	make	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	8	12	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	8	13	commitment	commitment	NN
work_4ezbiswdwvaltiifn3v3mawqzu	8	14	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	8	15	update	update	VB
work_4ezbiswdwvaltiifn3v3mawqzu	8	16	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	8	17	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	8	18	periodically	periodically	RB
work_4ezbiswdwvaltiifn3v3mawqzu	8	19	with	with	IN
work_4ezbiswdwvaltiifn3v3mawqzu	8	20	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	8	21	goal	goal	NN
work_4ezbiswdwvaltiifn3v3mawqzu	8	22	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	8	23	fine	fine	RB
work_4ezbiswdwvaltiifn3v3mawqzu	8	24	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	8	25	tuning	tuning	VB
work_4ezbiswdwvaltiifn3v3mawqzu	8	26	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	8	27	research	research	NN
work_4ezbiswdwvaltiifn3v3mawqzu	8	28	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	8	29	light	light	NN
work_4ezbiswdwvaltiifn3v3mawqzu	8	30	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	8	31	any	any	DT
work_4ezbiswdwvaltiifn3v3mawqzu	8	32	new	new	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	8	33	studies	study	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	8	34	that	that	WDT
work_4ezbiswdwvaltiifn3v3mawqzu	8	35	come	come	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	8	36	along	along	RP
work_4ezbiswdwvaltiifn3v3mawqzu	8	37	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	9	1	If	if	IN
work_4ezbiswdwvaltiifn3v3mawqzu	9	2	performed	perform	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	9	3	correctly	correctly	RB
work_4ezbiswdwvaltiifn3v3mawqzu	9	4	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	9	5	these	these	DT
work_4ezbiswdwvaltiifn3v3mawqzu	9	6	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	9	7	can	can	MD
work_4ezbiswdwvaltiifn3v3mawqzu	9	8	provide	provide	VB
work_4ezbiswdwvaltiifn3v3mawqzu	9	9	complete	complete	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	9	10	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	9	11	up	up	RB
work_4ezbiswdwvaltiifn3v3mawqzu	9	12	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	9	13	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	9	14	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	9	15	date	date	NN
work_4ezbiswdwvaltiifn3v3mawqzu	9	16	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	9	17	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	9	18	unbiased	unbiased	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	9	19	measurements	measurement	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	9	20	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	9	21	treat-	treat-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	9	22	ment	ment	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	9	23	effectiveness	effectiveness	NN
work_4ezbiswdwvaltiifn3v3mawqzu	9	24	by	by	IN
work_4ezbiswdwvaltiifn3v3mawqzu	9	25	using	use	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	9	26	metaanalytical	metaanalytical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	9	27	sta-	sta-	NN
work_4ezbiswdwvaltiifn3v3mawqzu	9	28	tistics	tistic	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	9	29	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	10	1	High	high	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	10	2	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	10	3	quality	quality	NN
work_4ezbiswdwvaltiifn3v3mawqzu	10	4	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	10	5	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	10	6	may	may	MD
work_4ezbiswdwvaltiifn3v3mawqzu	10	7	also	also	RB
work_4ezbiswdwvaltiifn3v3mawqzu	10	8	indicate	indicate	VB
work_4ezbiswdwvaltiifn3v3mawqzu	10	9	whether	whether	IN
work_4ezbiswdwvaltiifn3v3mawqzu	10	10	existing	exist	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	10	11	evidence	evidence	NN
work_4ezbiswdwvaltiifn3v3mawqzu	10	12	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	10	13	consistent	consistent	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	10	14	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	10	15	can	can	MD
work_4ezbiswdwvaltiifn3v3mawqzu	10	16	be	be	VB
work_4ezbiswdwvaltiifn3v3mawqzu	10	17	generalized	generalize	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	10	18	across	across	IN
work_4ezbiswdwvaltiifn3v3mawqzu	10	19	patient	patient	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	10	20	popula-	popula-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	10	21	tions	tion	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	10	22	or	or	CC
work_4ezbiswdwvaltiifn3v3mawqzu	10	23	variations	variation	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	10	24	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	10	25	treatment	treatment	NN
work_4ezbiswdwvaltiifn3v3mawqzu	10	26	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	10	27	Collier	Collier	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	10	28	et	et	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	10	29	al	al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	10	30	.	.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	10	31	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	10	32	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	10	33	;	;	:
work_4ezbiswdwvaltiifn3v3mawqzu	10	34	Parker	Parker	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	10	35	et	et	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	10	36	al	al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	10	37	.	.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	10	38	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	10	39	2004	2004	CD
work_4ezbiswdwvaltiifn3v3mawqzu	10	40	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	10	41	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	11	1	Why	why	WRB
work_4ezbiswdwvaltiifn3v3mawqzu	11	2	might	may	MD
work_4ezbiswdwvaltiifn3v3mawqzu	11	3	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	11	4	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	11	5	be	be	VB
work_4ezbiswdwvaltiifn3v3mawqzu	11	6	important	important	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	11	7	?	?	.
work_4ezbiswdwvaltiifn3v3mawqzu	12	1	Results	result	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	12	2	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	12	3	isolated	isolated	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	12	4	randomized	randomized	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	12	5	controlled	controlled	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	12	6	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	12	7	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	12	8	frequently	frequently	RB
work_4ezbiswdwvaltiifn3v3mawqzu	12	9	contradicted	contradict	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	12	10	by	by	IN
work_4ezbiswdwvaltiifn3v3mawqzu	12	11	subsequent	subsequent	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	12	12	stud-	stud-	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	12	13	ies	ies	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	12	14	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	12	15	Ioannidis	Ioannidis	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	12	16	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	12	17	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	12	18	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	12	19	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	13	1	Under	under	IN
work_4ezbiswdwvaltiifn3v3mawqzu	13	2	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	13	3	most	most	RBS
work_4ezbiswdwvaltiifn3v3mawqzu	13	4	rigorous	rigorous	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	13	5	study	study	NN
work_4ezbiswdwvaltiifn3v3mawqzu	13	6	design	design	NN
work_4ezbiswdwvaltiifn3v3mawqzu	13	7	conditions	condition	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	13	8	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	13	9	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	13	10	well	well	RB
work_4ezbiswdwvaltiifn3v3mawqzu	13	11	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	13	12	planned	plan	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	13	13	single	single	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	13	14	study	study	NN
work_4ezbiswdwvaltiifn3v3mawqzu	13	15	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	13	16	even	even	RB
work_4ezbiswdwvaltiifn3v3mawqzu	13	17	if	if	IN
work_4ezbiswdwvaltiifn3v3mawqzu	13	18	prospective	prospective	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	13	19	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	13	20	randomized	randomized	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	13	21	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	13	22	rarely	rarely	RB
work_4ezbiswdwvaltiifn3v3mawqzu	13	23	provides	provide	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	13	24	definitive	definitive	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	13	25	results	result	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	13	26	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	13	27	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	13	28	primary	primary	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	13	29	studies	study	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	13	30	tend	tend	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	13	31	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	13	32	overestimate	overestimate	VB
work_4ezbiswdwvaltiifn3v3mawqzu	13	33	treatment	treatment	NN
work_4ezbiswdwvaltiifn3v3mawqzu	13	34	effects	effect	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	13	35	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	14	1	A	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	14	2	recent	recent	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	14	3	study	study	NN
work_4ezbiswdwvaltiifn3v3mawqzu	14	4	reported	report	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	14	5	that	that	IN
work_4ezbiswdwvaltiifn3v3mawqzu	14	6	32	32	CD
work_4ezbiswdwvaltiifn3v3mawqzu	14	7	%	%	NN
work_4ezbiswdwvaltiifn3v3mawqzu	14	8	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	14	9	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	14	10	set	set	NN
work_4ezbiswdwvaltiifn3v3mawqzu	14	11	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	14	12	studies	study	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	14	13	with	with	IN
work_4ezbiswdwvaltiifn3v3mawqzu	14	14	at	at	RB
work_4ezbiswdwvaltiifn3v3mawqzu	14	15	least	least	JJS
work_4ezbiswdwvaltiifn3v3mawqzu	14	16	1,000	1,000	CD
work_4ezbiswdwvaltiifn3v3mawqzu	14	17	citations	citation	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	14	18	were	be	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	14	19	either	either	RB
work_4ezbiswdwvaltiifn3v3mawqzu	14	20	contradicted	contradict	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	14	21	by	by	IN
work_4ezbiswdwvaltiifn3v3mawqzu	14	22	or	or	CC
work_4ezbiswdwvaltiifn3v3mawqzu	14	23	reported	report	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	14	24	stronger	strong	JJR
work_4ezbiswdwvaltiifn3v3mawqzu	14	25	effects	effect	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	14	26	than	than	IN
work_4ezbiswdwvaltiifn3v3mawqzu	14	27	subsequent	subsequent	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	14	28	studies	study	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	14	29	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	14	30	Ioannidis	Ioannidis	NNPS
work_4ezbiswdwvaltiifn3v3mawqzu	14	31	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	14	32	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	14	33	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	14	34	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	15	1	Relying	rely	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	15	2	on	on	IN
work_4ezbiswdwvaltiifn3v3mawqzu	15	3	single	single	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	15	4	high	high	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	15	5	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	15	6	profile	profile	NN
work_4ezbiswdwvaltiifn3v3mawqzu	15	7	clinical	clinical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	15	8	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	15	9	can	can	MD
work_4ezbiswdwvaltiifn3v3mawqzu	15	10	therefore	therefore	RB
work_4ezbiswdwvaltiifn3v3mawqzu	15	11	be	be	VB
work_4ezbiswdwvaltiifn3v3mawqzu	15	12	harmful	harmful	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	15	13	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	15	14	patients	patient	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	15	15	’	’	POS
work_4ezbiswdwvaltiifn3v3mawqzu	15	16	health	health	NN
work_4ezbiswdwvaltiifn3v3mawqzu	15	17	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	16	1	Well	well	RB
work_4ezbiswdwvaltiifn3v3mawqzu	16	2	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	16	3	designed	design	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	16	4	randomized	randomized	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	16	5	controlled	controlled	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	16	6	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	16	7	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	16	8	excellent	excellent	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	16	9	when	when	WRB
work_4ezbiswdwvaltiifn3v3mawqzu	16	10	looking	look	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	16	11	at	at	IN
work_4ezbiswdwvaltiifn3v3mawqzu	16	12	effectiveness	effectiveness	NN
work_4ezbiswdwvaltiifn3v3mawqzu	16	13	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	16	14	though	though	IN
work_4ezbiswdwvaltiifn3v3mawqzu	16	15	many	many	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	16	16	fall	fall	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	16	17	short	short	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	16	18	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	16	19	quality	quality	NN
work_4ezbiswdwvaltiifn3v3mawqzu	16	20	reporting	reporting	NN
work_4ezbiswdwvaltiifn3v3mawqzu	16	21	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	16	22	safety	safety	NN
work_4ezbiswdwvaltiifn3v3mawqzu	16	23	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	16	24	adverse	adverse	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	16	25	events	event	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	16	26	associated	associate	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	16	27	with	with	IN
work_4ezbiswdwvaltiifn3v3mawqzu	16	28	an	an	DT
work_4ezbiswdwvaltiifn3v3mawqzu	16	29	inter-	inter-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	16	30	vention	vention	NN
work_4ezbiswdwvaltiifn3v3mawqzu	16	31	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	17	1	Quality	quality	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	17	2	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	17	3	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	17	4	often	often	RB
work_4ezbiswdwvaltiifn3v3mawqzu	17	5	have	have	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	17	6	increased	increase	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	17	7	power	power	NN
work_4ezbiswdwvaltiifn3v3mawqzu	17	8	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	17	9	decreased	decrease	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	17	10	bias	bias	NN
work_4ezbiswdwvaltiifn3v3mawqzu	17	11	as	as	IN
work_4ezbiswdwvaltiifn3v3mawqzu	17	12	com-	com-	NN
work_4ezbiswdwvaltiifn3v3mawqzu	17	13	pared	pare	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	17	14	with	with	IN
work_4ezbiswdwvaltiifn3v3mawqzu	17	15	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	17	16	individual	individual	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	17	17	studies	study	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	17	18	they	-PRON-	PRP
work_4ezbiswdwvaltiifn3v3mawqzu	17	19	include	include	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	17	20	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	17	21	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	17	22	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	17	23	careful	careful	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	17	24	pooling	pooling	NN
work_4ezbiswdwvaltiifn3v3mawqzu	17	25	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	17	26	treatment	treatment	NN
work_4ezbiswdwvaltiifn3v3mawqzu	17	27	effects	effect	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	17	28	can	can	MD
work_4ezbiswdwvaltiifn3v3mawqzu	17	29	provide	provide	VB
work_4ezbiswdwvaltiifn3v3mawqzu	17	30	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	17	31	most	most	RBS
work_4ezbiswdwvaltiifn3v3mawqzu	17	32	accurate	accurate	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	17	33	overall	overall	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	17	34	assessment	assessment	NN
work_4ezbiswdwvaltiifn3v3mawqzu	17	35	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	17	36	an	an	DT
work_4ezbiswdwvaltiifn3v3mawqzu	17	37	intervention	intervention	NN
work_4ezbiswdwvaltiifn3v3mawqzu	17	38	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	18	1	Benefits	benefit	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	18	2	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	18	3	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	18	4	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	18	5	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	18	6	biomedical	biomedical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	18	7	literature	literature	NN
work_4ezbiswdwvaltiifn3v3mawqzu	18	8	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	19	1	Systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	19	2	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	19	3	may	may	MD
work_4ezbiswdwvaltiifn3v3mawqzu	19	4	save	save	VB
work_4ezbiswdwvaltiifn3v3mawqzu	19	5	both	both	DT
work_4ezbiswdwvaltiifn3v3mawqzu	19	6	lives	life	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	19	7	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	19	8	resources	resource	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	19	9	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	20	1	In	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	20	2	addition	addition	NN
work_4ezbiswdwvaltiifn3v3mawqzu	20	3	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	20	4	adopt-	adopt-	XX
work_4ezbiswdwvaltiifn3v3mawqzu	20	5	ing	e	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	20	6	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	20	7	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	20	8	approach	approach	NN
work_4ezbiswdwvaltiifn3v3mawqzu	20	9	that	that	WDT
work_4ezbiswdwvaltiifn3v3mawqzu	20	10	minimizes	minimize	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	20	11	bias	bias	NN
work_4ezbiswdwvaltiifn3v3mawqzu	20	12	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	20	13	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	20	14	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	20	15	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	20	16	all	all	DT
work_4ezbiswdwvaltiifn3v3mawqzu	20	17	published	publish	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	20	18	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	20	19	unpublished	unpublishe	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	20	20	randomized	randomized	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	20	21	controlled	control	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	20	22	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	20	23	also	also	RB
work_4ezbiswdwvaltiifn3v3mawqzu	20	24	have	have	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	20	25	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	20	26	potential	potential	NN
work_4ezbiswdwvaltiifn3v3mawqzu	20	27	through	through	IN
work_4ezbiswdwvaltiifn3v3mawqzu	20	28	appropriate	appropriate	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	20	29	use	use	NN
work_4ezbiswdwvaltiifn3v3mawqzu	20	30	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	20	31	metaanalysis	metaanalysis	NN
work_4ezbiswdwvaltiifn3v3mawqzu	20	32	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	20	33	produce	produce	VB
work_4ezbiswdwvaltiifn3v3mawqzu	20	34	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	20	35	more	more	RBR
work_4ezbiswdwvaltiifn3v3mawqzu	20	36	precise	precise	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	20	37	estimate	estimate	NN
work_4ezbiswdwvaltiifn3v3mawqzu	20	38	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	20	39	treatment	treatment	NN
work_4ezbiswdwvaltiifn3v3mawqzu	20	40	effect	effect	NN
work_4ezbiswdwvaltiifn3v3mawqzu	20	41	so	so	IN
work_4ezbiswdwvaltiifn3v3mawqzu	20	42	that	that	DT
work_4ezbiswdwvaltiifn3v3mawqzu	20	43	small	small	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	20	44	but	but	CC
work_4ezbiswdwvaltiifn3v3mawqzu	20	45	clinically	clinically	RB
work_4ezbiswdwvaltiifn3v3mawqzu	20	46	important	important	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	20	47	effects	effect	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	20	48	become	become	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	20	49	apparent	apparent	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	20	50	among	among	IN
work_4ezbiswdwvaltiifn3v3mawqzu	20	51	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	20	52	group	group	NN
work_4ezbiswdwvaltiifn3v3mawqzu	20	53	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	20	54	apparently	apparently	RB
work_4ezbiswdwvaltiifn3v3mawqzu	20	55	conflicting	conflict	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	20	56	sin-	sin-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	20	57	gle	gle	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	20	58	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	20	59	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	21	1	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	21	2	human	human	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	21	3	cost	cost	NN
work_4ezbiswdwvaltiifn3v3mawqzu	21	4	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	21	5	failing	fail	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	21	6	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	21	7	produce	produce	VB
work_4ezbiswdwvaltiifn3v3mawqzu	21	8	such	such	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	21	9	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	21	10	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	21	11	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	21	12	illustrated	illustrate	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	21	13	by	by	IN
work_4ezbiswdwvaltiifn3v3mawqzu	21	14	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	21	15	Journal	Journal	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	21	16	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	21	17	Investigative	Investigative	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	21	18	Dermatology	Dermatology	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	21	19	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	21	20	2006	2006	CD
work_4ezbiswdwvaltiifn3v3mawqzu	21	21	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	21	22	126	126	CD
work_4ezbiswdwvaltiifn3v3mawqzu	21	23	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	21	24	2357	2357	CD
work_4ezbiswdwvaltiifn3v3mawqzu	21	25	–	–	:
work_4ezbiswdwvaltiifn3v3mawqzu	21	26	2360	2360	CD
work_4ezbiswdwvaltiifn3v3mawqzu	21	27	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	21	28	doi:10.1038	doi:10.1038	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	21	29	/	/	SYM
work_4ezbiswdwvaltiifn3v3mawqzu	21	30	sj.jid.5700560	sj.jid.5700560	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	21	31	2358	2358	CD
work_4ezbiswdwvaltiifn3v3mawqzu	21	32	Journal	Journal	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	21	33	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	21	34	Investigative	Investigative	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	21	35	Dermatology	Dermatology	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	21	36	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	21	37	2006	2006	CD
work_4ezbiswdwvaltiifn3v3mawqzu	21	38	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	21	39	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	21	40	Volume	volume	NN
work_4ezbiswdwvaltiifn3v3mawqzu	21	41	126	126	CD
work_4ezbiswdwvaltiifn3v3mawqzu	21	42	©	©	CD
work_4ezbiswdwvaltiifn3v3mawqzu	21	43	2006	2006	CD
work_4ezbiswdwvaltiifn3v3mawqzu	21	44	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	21	45	Society	Society	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	21	46	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	21	47	Investigative	Investigative	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	21	48	Dermatology	Dermatology	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	21	49	life	life	NN
work_4ezbiswdwvaltiifn3v3mawqzu	21	50	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	21	51	saving	save	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	21	52	potential	potential	NN
work_4ezbiswdwvaltiifn3v3mawqzu	21	53	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	21	54	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	21	55	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	21	56	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	21	57	conducted	conduct	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	21	58	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	21	59	examine	examine	VB
work_4ezbiswdwvaltiifn3v3mawqzu	21	60	infant	infant	NN
work_4ezbiswdwvaltiifn3v3mawqzu	21	61	sleeping	sleeping	NN
work_4ezbiswdwvaltiifn3v3mawqzu	21	62	position	position	NN
work_4ezbiswdwvaltiifn3v3mawqzu	21	63	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	21	64	sudden	sudden	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	21	65	infant	infant	NN
work_4ezbiswdwvaltiifn3v3mawqzu	21	66	death	death	NN
work_4ezbiswdwvaltiifn3v3mawqzu	21	67	syndrome	syndrome	NN
work_4ezbiswdwvaltiifn3v3mawqzu	21	68	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	22	1	Although	although	IN
work_4ezbiswdwvaltiifn3v3mawqzu	22	2	advice	advice	NN
work_4ezbiswdwvaltiifn3v3mawqzu	22	3	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	22	4	place	place	VB
work_4ezbiswdwvaltiifn3v3mawqzu	22	5	infants	infant	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	22	6	on	on	IN
work_4ezbiswdwvaltiifn3v3mawqzu	22	7	their	-PRON-	PRP$
work_4ezbiswdwvaltiifn3v3mawqzu	22	8	backs	back	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	22	9	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	22	10	sleep	sleep	VB
work_4ezbiswdwvaltiifn3v3mawqzu	22	11	was	be	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	22	12	widely	widely	RB
work_4ezbiswdwvaltiifn3v3mawqzu	22	13	available	available	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	22	14	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	22	15	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	22	16	early	early	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	22	17	1990s	1990	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	22	18	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	22	19	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	22	20	authors	author	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	22	21	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	22	22	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	22	23	sudden	sudden	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	22	24	infant	infant	NN
work_4ezbiswdwvaltiifn3v3mawqzu	22	25	death	death	NN
work_4ezbiswdwvaltiifn3v3mawqzu	22	26	syndrome	syndrome	NN
work_4ezbiswdwvaltiifn3v3mawqzu	22	27	study	study	NN
work_4ezbiswdwvaltiifn3v3mawqzu	22	28	showed	show	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	22	29	that	that	IN
work_4ezbiswdwvaltiifn3v3mawqzu	22	30	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	22	31	mortality	mortality	NN
work_4ezbiswdwvaltiifn3v3mawqzu	22	32	benefit	benefit	NN
work_4ezbiswdwvaltiifn3v3mawqzu	22	33	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	22	34	this	this	DT
work_4ezbiswdwvaltiifn3v3mawqzu	22	35	sleep	sleep	NN
work_4ezbiswdwvaltiifn3v3mawqzu	22	36	position	position	NN
work_4ezbiswdwvaltiifn3v3mawqzu	22	37	would	would	MD
work_4ezbiswdwvaltiifn3v3mawqzu	22	38	have	have	VB
work_4ezbiswdwvaltiifn3v3mawqzu	22	39	been	be	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	22	40	apparent	apparent	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	22	41	if	if	IN
work_4ezbiswdwvaltiifn3v3mawqzu	22	42	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	22	43	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	22	44	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	22	45	had	have	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	22	46	been	be	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	22	47	performed	perform	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	22	48	any	any	DT
work_4ezbiswdwvaltiifn3v3mawqzu	22	49	time	time	NN
work_4ezbiswdwvaltiifn3v3mawqzu	22	50	after	after	IN
work_4ezbiswdwvaltiifn3v3mawqzu	22	51	1970	1970	CD
work_4ezbiswdwvaltiifn3v3mawqzu	22	52	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	22	53	Gilbert	Gilbert	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	22	54	et	et	FW
work_4ezbiswdwvaltiifn3v3mawqzu	22	55	al	al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	22	56	.	.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	22	57	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	22	58	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	22	59	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	22	60	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	23	1	Such	such	PDT
work_4ezbiswdwvaltiifn3v3mawqzu	23	2	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	23	3	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	23	4	potentially	potentially	RB
work_4ezbiswdwvaltiifn3v3mawqzu	23	5	could	could	MD
work_4ezbiswdwvaltiifn3v3mawqzu	23	6	have	have	VB
work_4ezbiswdwvaltiifn3v3mawqzu	23	7	saved	save	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	23	8	60,000	60,000	CD
work_4ezbiswdwvaltiifn3v3mawqzu	23	9	infant	infant	NN
work_4ezbiswdwvaltiifn3v3mawqzu	23	10	lives	live	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	23	11	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	23	12	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	23	13	United	United	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	23	14	Kingdom	Kingdom	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	23	15	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	23	16	Europe	Europe	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	23	17	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	23	18	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	23	19	United	United	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	23	20	States	States	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	23	21	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	23	22	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	23	23	Australia	Australia	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	23	24	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	24	1	Quality	quality	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	24	2	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	24	3	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	24	4	also	also	RB
work_4ezbiswdwvaltiifn3v3mawqzu	24	5	possess	possess	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	24	6	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	24	7	potential	potential	NN
work_4ezbiswdwvaltiifn3v3mawqzu	24	8	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	24	9	save	save	VB
work_4ezbiswdwvaltiifn3v3mawqzu	24	10	biomedical	biomedical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	24	11	resources	resource	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	24	12	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	25	1	Cumulative	cumulative	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	25	2	metaanalytical	metaanalytical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	25	3	tech-	tech-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	25	4	niques	nique	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	25	5	on	on	IN
work_4ezbiswdwvaltiifn3v3mawqzu	25	6	64	64	CD
work_4ezbiswdwvaltiifn3v3mawqzu	25	7	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	25	8	investigating	investigate	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	25	9	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	25	10	effectiveness	effectiveness	NN
work_4ezbiswdwvaltiifn3v3mawqzu	25	11	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	25	12	aprotinin	aprotinin	NN
work_4ezbiswdwvaltiifn3v3mawqzu	25	13	showed	show	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	25	14	that	that	IN
work_4ezbiswdwvaltiifn3v3mawqzu	25	15	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	25	16	effectiveness	effectiveness	NN
work_4ezbiswdwvaltiifn3v3mawqzu	25	17	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	25	18	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	25	19	drug	drug	NN
work_4ezbiswdwvaltiifn3v3mawqzu	25	20	was	be	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	25	21	apparent	apparent	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	25	22	after	after	IN
work_4ezbiswdwvaltiifn3v3mawqzu	25	23	only	only	RB
work_4ezbiswdwvaltiifn3v3mawqzu	25	24	12	12	CD
work_4ezbiswdwvaltiifn3v3mawqzu	25	25	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	25	26	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	25	27	Fergusson	Fergusson	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	25	28	et	et	FW
work_4ezbiswdwvaltiifn3v3mawqzu	25	29	al	al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	25	30	.	.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	25	31	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	25	32	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	25	33	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	25	34	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	26	1	Thus	thus	RB
work_4ezbiswdwvaltiifn3v3mawqzu	26	2	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	26	3	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	26	4	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	26	5	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	26	6	aprotinin	aprotinin	NN
work_4ezbiswdwvaltiifn3v3mawqzu	26	7	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	26	8	perioperative	perioperative	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	26	9	bleeding	bleeding	NN
work_4ezbiswdwvaltiifn3v3mawqzu	26	10	identified	identify	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	26	11	52	52	CD
work_4ezbiswdwvaltiifn3v3mawqzu	26	12	unnecessary	unnecessary	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	26	13	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	26	14	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	27	1	Had	have	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	27	2	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	27	3	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	27	4	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	27	5	been	be	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	27	6	performed	perform	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	27	7	after	after	IN
work_4ezbiswdwvaltiifn3v3mawqzu	27	8	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	27	9	twelfth	twelfth	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	27	10	study	study	NN
work_4ezbiswdwvaltiifn3v3mawqzu	27	11	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	27	12	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	27	13	treatment	treatment	NN
work_4ezbiswdwvaltiifn3v3mawqzu	27	14	effect	effect	NN
work_4ezbiswdwvaltiifn3v3mawqzu	27	15	would	would	MD
work_4ezbiswdwvaltiifn3v3mawqzu	27	16	have	have	VB
work_4ezbiswdwvaltiifn3v3mawqzu	27	17	been	be	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	27	18	apparent	apparent	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	27	19	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	27	20	duplicate	duplicate	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	27	21	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	27	22	would	would	MD
work_4ezbiswdwvaltiifn3v3mawqzu	27	23	have	have	VB
work_4ezbiswdwvaltiifn3v3mawqzu	27	24	been	be	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	27	25	avoided	avoid	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	27	26	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	27	27	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	27	28	patients	patient	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	27	29	would	would	MD
work_4ezbiswdwvaltiifn3v3mawqzu	27	30	have	have	VB
work_4ezbiswdwvaltiifn3v3mawqzu	27	31	experienced	experience	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	27	32	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	27	33	benefit	benefit	NN
work_4ezbiswdwvaltiifn3v3mawqzu	27	34	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	27	35	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	27	36	useful	useful	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	27	37	drug	drug	NN
work_4ezbiswdwvaltiifn3v3mawqzu	27	38	ten	ten	CD
work_4ezbiswdwvaltiifn3v3mawqzu	27	39	years	year	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	27	40	earlier	early	RBR
work_4ezbiswdwvaltiifn3v3mawqzu	27	41	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	28	1	Antenatal	antenatal	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	28	2	corticosteroid	corticosteroid	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	28	3	therapy	therapy	NN
work_4ezbiswdwvaltiifn3v3mawqzu	28	4	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	28	5	fetal	fetal	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	28	6	lung	lung	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	28	7	matura-	matura-	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	28	8	tion	tion	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	28	9	reduces	reduce	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	28	10	mortality	mortality	NN
work_4ezbiswdwvaltiifn3v3mawqzu	28	11	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	28	12	respiratory	respiratory	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	28	13	distress	distress	NN
work_4ezbiswdwvaltiifn3v3mawqzu	28	14	syndrome	syndrome	NN
work_4ezbiswdwvaltiifn3v3mawqzu	28	15	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	28	16	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	28	17	intraventricular	intraventricular	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	28	18	hemorrhage	hemorrhage	NN
work_4ezbiswdwvaltiifn3v3mawqzu	28	19	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	28	20	preterm	preterm	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	28	21	infants	infant	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	28	22	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	28	23	Crowley	Crowley	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	28	24	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	28	25	2000	2000	CD
work_4ezbiswdwvaltiifn3v3mawqzu	28	26	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	28	27	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	29	1	Although	although	IN
work_4ezbiswdwvaltiifn3v3mawqzu	29	2	corticosteroids	corticosteroid	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	29	3	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	29	4	routinely	routinely	RB
work_4ezbiswdwvaltiifn3v3mawqzu	29	5	used	use	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	29	6	today	today	NN
work_4ezbiswdwvaltiifn3v3mawqzu	29	7	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	29	8	accelerate	accelerate	VB
work_4ezbiswdwvaltiifn3v3mawqzu	29	9	fetal	fetal	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	29	10	lung	lung	NN
work_4ezbiswdwvaltiifn3v3mawqzu	29	11	maturity	maturity	NN
work_4ezbiswdwvaltiifn3v3mawqzu	29	12	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	29	13	infants	infant	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	29	14	at	at	IN
work_4ezbiswdwvaltiifn3v3mawqzu	29	15	risk	risk	NN
work_4ezbiswdwvaltiifn3v3mawqzu	29	16	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	29	17	prema-	prema-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	29	18	ture	ture	NN
work_4ezbiswdwvaltiifn3v3mawqzu	29	19	delivery	delivery	NN
work_4ezbiswdwvaltiifn3v3mawqzu	29	20	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	29	21	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	29	22	medical	medical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	29	23	community	community	NN
work_4ezbiswdwvaltiifn3v3mawqzu	29	24	did	do	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	29	25	not	not	RB
work_4ezbiswdwvaltiifn3v3mawqzu	29	26	embrace	embrace	VB
work_4ezbiswdwvaltiifn3v3mawqzu	29	27	this	this	DT
work_4ezbiswdwvaltiifn3v3mawqzu	29	28	treatment	treatment	NN
work_4ezbiswdwvaltiifn3v3mawqzu	29	29	unanimously	unanimously	RB
work_4ezbiswdwvaltiifn3v3mawqzu	29	30	during	during	IN
work_4ezbiswdwvaltiifn3v3mawqzu	29	31	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	29	32	1970s	1970	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	29	33	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	29	34	1980s	1980	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	29	35	despite	despite	IN
work_4ezbiswdwvaltiifn3v3mawqzu	29	36	repeated	repeat	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	29	37	randomized	randomized	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	29	38	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	29	39	providing	provide	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	29	40	evidence	evidence	NN
work_4ezbiswdwvaltiifn3v3mawqzu	29	41	supporting	support	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	29	42	their	-PRON-	PRP$
work_4ezbiswdwvaltiifn3v3mawqzu	29	43	use	use	NN
work_4ezbiswdwvaltiifn3v3mawqzu	29	44	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	30	1	A	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	30	2	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	30	3	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	30	4	provided	provide	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	30	5	incontrovertible	incontrovertible	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	30	6	evidence	evidence	NN
work_4ezbiswdwvaltiifn3v3mawqzu	30	7	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	30	8	favor	favor	NN
work_4ezbiswdwvaltiifn3v3mawqzu	30	9	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	30	10	antenatal	antenatal	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	30	11	corticosteroid	corticosteroid	NN
work_4ezbiswdwvaltiifn3v3mawqzu	30	12	therapy	therapy	NN
work_4ezbiswdwvaltiifn3v3mawqzu	30	13	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	30	14	revealed	reveal	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	30	15	that	that	IN
work_4ezbiswdwvaltiifn3v3mawqzu	30	16	tens	ten	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	30	17	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	30	18	thousands	thousand	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	30	19	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	30	20	premature	premature	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	30	21	babies	baby	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	30	22	have	have	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	30	23	needed	need	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	30	24	more	more	RBR
work_4ezbiswdwvaltiifn3v3mawqzu	30	25	extensive	extensive	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	30	26	therapy	therapy	NN
work_4ezbiswdwvaltiifn3v3mawqzu	30	27	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	30	28	suffered	suffer	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	30	29	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	30	30	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	30	31	died	die	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	30	32	unneces-	unneces-	NN
work_4ezbiswdwvaltiifn3v3mawqzu	30	33	sarily	sarily	RB
work_4ezbiswdwvaltiifn3v3mawqzu	30	34	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	30	35	Crowley	Crowley	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	30	36	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	30	37	2000	2000	CD
work_4ezbiswdwvaltiifn3v3mawqzu	30	38	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	30	39	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	31	1	These	these	DT
work_4ezbiswdwvaltiifn3v3mawqzu	31	2	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	31	3	just	just	RB
work_4ezbiswdwvaltiifn3v3mawqzu	31	4	three	three	CD
work_4ezbiswdwvaltiifn3v3mawqzu	31	5	examples	example	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	31	6	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	31	7	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	31	8	costs	cost	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	31	9	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	31	10	failure	failure	NN
work_4ezbiswdwvaltiifn3v3mawqzu	31	11	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	31	12	perform	perform	VB
work_4ezbiswdwvaltiifn3v3mawqzu	31	13	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	31	14	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	31	15	up	up	RB
work_4ezbiswdwvaltiifn3v3mawqzu	31	16	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	31	17	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	31	18	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	31	19	date	date	NN
work_4ezbiswdwvaltiifn3v3mawqzu	31	20	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	31	21	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	31	22	randomized	randomized	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	31	23	con-	con-	NN
work_4ezbiswdwvaltiifn3v3mawqzu	31	24	trolled	troll	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	31	25	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	31	26	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	31	27	health	health	NN
work_4ezbiswdwvaltiifn3v3mawqzu	31	28	care	care	NN
work_4ezbiswdwvaltiifn3v3mawqzu	31	29	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	31	30	areas	area	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	31	31	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	31	32	medicine	medicine	NN
work_4ezbiswdwvaltiifn3v3mawqzu	31	33	outside	outside	RB
work_4ezbiswdwvaltiifn3v3mawqzu	31	34	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	31	35	dermatology	dermatology	NN
work_4ezbiswdwvaltiifn3v3mawqzu	31	36	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	32	1	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	32	2	question	question	NN
work_4ezbiswdwvaltiifn3v3mawqzu	32	3	remains	remain	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	32	4	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	32	5	therefore	therefore	RB
work_4ezbiswdwvaltiifn3v3mawqzu	32	6	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	32	7	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	32	8	what	what	WDT
work_4ezbiswdwvaltiifn3v3mawqzu	32	9	extent	extent	NN
work_4ezbiswdwvaltiifn3v3mawqzu	32	10	such	such	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	32	11	messages	message	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	32	12	apply	apply	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	32	13	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	32	14	dermatology	dermatology	NN
work_4ezbiswdwvaltiifn3v3mawqzu	32	15	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	33	1	Systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	33	2	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	33	3	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	33	4	dermatology	dermatology	NN
work_4ezbiswdwvaltiifn3v3mawqzu	33	5	Risk	Risk	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	33	6	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	33	7	melanoma	melanoma	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	33	8	from	from	IN
work_4ezbiswdwvaltiifn3v3mawqzu	33	9	indoor	indoor	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	33	10	UV	UV	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	33	11	tanning	tanning	NN
work_4ezbiswdwvaltiifn3v3mawqzu	33	12	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	34	1	Systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	34	2	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	34	3	may	may	MD
work_4ezbiswdwvaltiifn3v3mawqzu	34	4	reveal	reveal	VB
work_4ezbiswdwvaltiifn3v3mawqzu	34	5	clear	clear	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	34	6	outcomes	outcome	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	34	7	when	when	WRB
work_4ezbiswdwvaltiifn3v3mawqzu	34	8	individual	individual	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	34	9	stud-	stud-	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	34	10	ies	ies	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	34	11	report	report	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	34	12	widely	widely	RB
work_4ezbiswdwvaltiifn3v3mawqzu	34	13	varying	vary	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	34	14	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	34	15	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	34	16	even	even	RB
work_4ezbiswdwvaltiifn3v3mawqzu	34	17	contrasting	contrast	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	34	18	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	34	19	results	result	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	34	20	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	35	1	This	this	DT
work_4ezbiswdwvaltiifn3v3mawqzu	35	2	point	point	NN
work_4ezbiswdwvaltiifn3v3mawqzu	35	3	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	35	4	illustrated	illustrate	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	35	5	by	by	IN
work_4ezbiswdwvaltiifn3v3mawqzu	35	6	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	35	7	recent	recent	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	35	8	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	35	9	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	35	10	performed	perform	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	35	11	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	35	12	examine	examine	VB
work_4ezbiswdwvaltiifn3v3mawqzu	35	13	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	35	14	risk	risk	NN
work_4ezbiswdwvaltiifn3v3mawqzu	35	15	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	35	16	malignant	malignant	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	35	17	melanoma	melanoma	NN
work_4ezbiswdwvaltiifn3v3mawqzu	35	18	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	35	19	relation	relation	NN
work_4ezbiswdwvaltiifn3v3mawqzu	35	20	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	35	21	artificial	artificial	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	35	22	UV	uv	NN
work_4ezbiswdwvaltiifn3v3mawqzu	35	23	radiation	radiation	NN
work_4ezbiswdwvaltiifn3v3mawqzu	35	24	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	35	25	Gallagher	Gallagher	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	35	26	et	et	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	35	27	al	al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	35	28	.	.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	35	29	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	35	30	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	35	31	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	35	32	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	36	1	Because	because	IN
work_4ezbiswdwvaltiifn3v3mawqzu	36	2	exposure	exposure	NN
work_4ezbiswdwvaltiifn3v3mawqzu	36	3	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	36	4	artificial	artificial	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	36	5	UV	UV	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	36	6	radiation	radiation	NN
work_4ezbiswdwvaltiifn3v3mawqzu	36	7	through	through	IN
work_4ezbiswdwvaltiifn3v3mawqzu	36	8	sunlamp	sunlamp	NN
work_4ezbiswdwvaltiifn3v3mawqzu	36	9	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	36	10	sunbed	sunbed	NN
work_4ezbiswdwvaltiifn3v3mawqzu	36	11	use	use	NN
work_4ezbiswdwvaltiifn3v3mawqzu	36	12	may	may	MD
work_4ezbiswdwvaltiifn3v3mawqzu	36	13	be	be	VB
work_4ezbiswdwvaltiifn3v3mawqzu	36	14	intense	intense	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	36	15	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	36	16	intermittent	intermittent	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	36	17	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	36	18	concern	concern	NN
work_4ezbiswdwvaltiifn3v3mawqzu	36	19	arose	arise	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	36	20	that	that	IN
work_4ezbiswdwvaltiifn3v3mawqzu	36	21	these	these	DT
work_4ezbiswdwvaltiifn3v3mawqzu	36	22	devices	device	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	36	23	might	may	MD
work_4ezbiswdwvaltiifn3v3mawqzu	36	24	increase	increase	VB
work_4ezbiswdwvaltiifn3v3mawqzu	36	25	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	36	26	risk	risk	NN
work_4ezbiswdwvaltiifn3v3mawqzu	36	27	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	36	28	developing	develop	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	36	29	melanoma	melanoma	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	36	30	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	36	31	Elwood	Elwood	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	36	32	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	36	33	Jopson	Jopson	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	36	34	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	36	35	1997	1997	CD
work_4ezbiswdwvaltiifn3v3mawqzu	36	36	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	36	37	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	37	1	Studies	study	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	37	2	performed	perform	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	37	3	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	37	4	identify	identify	VB
work_4ezbiswdwvaltiifn3v3mawqzu	37	5	any	any	DT
work_4ezbiswdwvaltiifn3v3mawqzu	37	6	potential	potential	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	37	7	risk	risk	NN
work_4ezbiswdwvaltiifn3v3mawqzu	37	8	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	37	9	developing	develop	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	37	10	melanoma	melanoma	NN
work_4ezbiswdwvaltiifn3v3mawqzu	37	11	from	from	IN
work_4ezbiswdwvaltiifn3v3mawqzu	37	12	exposure	exposure	NN
work_4ezbiswdwvaltiifn3v3mawqzu	37	13	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	37	14	sunless	sunless	VB
work_4ezbiswdwvaltiifn3v3mawqzu	37	15	tanning	tanning	NN
work_4ezbiswdwvaltiifn3v3mawqzu	37	16	devices	device	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	37	17	have	have	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	37	18	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	37	19	however	however	RB
work_4ezbiswdwvaltiifn3v3mawqzu	37	20	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	37	21	includ-	includ-	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	37	22	ed	ed	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	37	23	low	low	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	37	24	numbers	number	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	37	25	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	37	26	exposed	expose	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	37	27	individuals	individual	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	37	28	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	37	29	have	have	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	37	30	reported	report	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	37	31	inconclusive	inconclusive	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	37	32	results	result	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	37	33	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	37	34	Elwood	Elwood	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	37	35	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	37	36	Jopson	Jopson	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	37	37	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	37	38	1997	1997	CD
work_4ezbiswdwvaltiifn3v3mawqzu	37	39	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	37	40	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	38	1	By	by	IN
work_4ezbiswdwvaltiifn3v3mawqzu	38	2	com-	com-	NN
work_4ezbiswdwvaltiifn3v3mawqzu	38	3	bining	bin	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	38	4	individual	individual	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	38	5	study	study	NN
work_4ezbiswdwvaltiifn3v3mawqzu	38	6	results	result	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	38	7	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	38	8	Gallagher	Gallagher	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	38	9	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	38	10	colleagues	colleague	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	38	11	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	38	12	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	38	13	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	38	14	were	be	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	38	15	able	able	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	38	16	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	38	17	identify	identify	VB
work_4ezbiswdwvaltiifn3v3mawqzu	38	18	significant	significant	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	38	19	increased	increase	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	38	20	risk	risk	NN
work_4ezbiswdwvaltiifn3v3mawqzu	38	21	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	38	22	melanoma	melanoma	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	38	23	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	38	24	people	people	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	38	25	exposed	expose	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	38	26	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	38	27	artificial	artificial	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	38	28	tanning	tanning	NN
work_4ezbiswdwvaltiifn3v3mawqzu	38	29	devices	device	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	38	30	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	39	1	Trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	39	2	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	39	3	topical	topical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	39	4	immunomodulating	immunomodulating	NN
work_4ezbiswdwvaltiifn3v3mawqzu	39	5	medications	medication	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	39	6	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	39	7	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	39	8	“	"	``
work_4ezbiswdwvaltiifn3v3mawqzu	39	9	me	-PRON-	PRP
work_4ezbiswdwvaltiifn3v3mawqzu	39	10	-	-	:
work_4ezbiswdwvaltiifn3v3mawqzu	39	11	too	too	RB
work_4ezbiswdwvaltiifn3v3mawqzu	39	12	”	"	''
work_4ezbiswdwvaltiifn3v3mawqzu	39	13	phenomenon	phenomenon	NN
work_4ezbiswdwvaltiifn3v3mawqzu	39	14	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	40	1	Systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	40	2	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	40	3	may	may	MD
work_4ezbiswdwvaltiifn3v3mawqzu	40	4	suppress	suppress	VB
work_4ezbiswdwvaltiifn3v3mawqzu	40	5	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	40	6	“	"	``
work_4ezbiswdwvaltiifn3v3mawqzu	40	7	me	-PRON-	PRP
work_4ezbiswdwvaltiifn3v3mawqzu	40	8	-	-	:
work_4ezbiswdwvaltiifn3v3mawqzu	40	9	too	too	RB
work_4ezbiswdwvaltiifn3v3mawqzu	40	10	”	"	''
work_4ezbiswdwvaltiifn3v3mawqzu	40	11	phenomenon	phenomenon	NN
work_4ezbiswdwvaltiifn3v3mawqzu	40	12	common	common	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	40	13	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	40	14	today	today	NN
work_4ezbiswdwvaltiifn3v3mawqzu	40	15	’s	’s	POS
work_4ezbiswdwvaltiifn3v3mawqzu	40	16	industry-	industry-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	40	17	driven	drive	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	40	18	research	research	NN
work_4ezbiswdwvaltiifn3v3mawqzu	40	19	environment	environment	NN
work_4ezbiswdwvaltiifn3v3mawqzu	40	20	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	41	1	New	new	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	41	2	medications	medication	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	41	3	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	41	4	marketed	market	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	41	5	heavily	heavily	RB
work_4ezbiswdwvaltiifn3v3mawqzu	41	6	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	41	7	physicians	physician	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	41	8	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	41	9	consumers	consumer	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	41	10	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	42	1	Trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	42	2	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	42	3	new	new	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	42	4	pharma-	pharma-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	42	5	ceutical	ceutical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	42	6	agents	agent	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	42	7	often	often	RB
work_4ezbiswdwvaltiifn3v3mawqzu	42	8	fail	fail	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	42	9	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	42	10	compare	compare	VB
work_4ezbiswdwvaltiifn3v3mawqzu	42	11	crucial	crucial	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	42	12	active	active	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	42	13	compara-	compara-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	42	14	tors	tor	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	42	15	with	with	IN
work_4ezbiswdwvaltiifn3v3mawqzu	42	16	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	42	17	study	study	NN
work_4ezbiswdwvaltiifn3v3mawqzu	42	18	drug	drug	NN
work_4ezbiswdwvaltiifn3v3mawqzu	42	19	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	43	1	Licensing	licensing	NN
work_4ezbiswdwvaltiifn3v3mawqzu	43	2	systems	system	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	43	3	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	43	4	medicines	medicine	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	43	5	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	43	6	Europe	Europe	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	43	7	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	43	8	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	43	9	United	United	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	43	10	States	States	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	43	11	only	only	RB
work_4ezbiswdwvaltiifn3v3mawqzu	43	12	require	require	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	43	13	new	new	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	43	14	drugs	drug	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	43	15	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	43	16	show	show	VB
work_4ezbiswdwvaltiifn3v3mawqzu	43	17	efficacy	efficacy	NN
work_4ezbiswdwvaltiifn3v3mawqzu	43	18	above	above	IN
work_4ezbiswdwvaltiifn3v3mawqzu	43	19	placebo	placebo	NN
work_4ezbiswdwvaltiifn3v3mawqzu	43	20	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	43	21	vehicle	vehicle	NN
work_4ezbiswdwvaltiifn3v3mawqzu	43	22	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	43	23	leading	lead	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	43	24	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	43	25	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	43	26	large	large	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	43	27	influx	influx	NN
work_4ezbiswdwvaltiifn3v3mawqzu	43	28	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	43	29	new	new	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	43	30	medications	medication	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	43	31	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	43	32	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	43	33	market	market	NN
work_4ezbiswdwvaltiifn3v3mawqzu	43	34	with	with	IN
work_4ezbiswdwvaltiifn3v3mawqzu	43	35	considerable	considerable	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	43	36	increas-	increas-	NN
work_4ezbiswdwvaltiifn3v3mawqzu	43	37	ing	ing	NN
work_4ezbiswdwvaltiifn3v3mawqzu	43	38	costs	cost	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	43	39	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	43	40	government	government	NN
work_4ezbiswdwvaltiifn3v3mawqzu	43	41	drug	drug	NN
work_4ezbiswdwvaltiifn3v3mawqzu	43	42	budgets	budget	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	43	43	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	43	44	Morgan	Morgan	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	43	45	et	et	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	43	46	al	al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	43	47	.	.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	43	48	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	43	49	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	43	50	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	43	51	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	44	1	Results	result	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	44	2	from	from	IN
work_4ezbiswdwvaltiifn3v3mawqzu	44	3	studies	study	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	44	4	lacking	lack	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	44	5	comparison	comparison	NN
work_4ezbiswdwvaltiifn3v3mawqzu	44	6	with	with	IN
work_4ezbiswdwvaltiifn3v3mawqzu	44	7	traditional	traditional	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	44	8	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	44	9	often	often	RB
work_4ezbiswdwvaltiifn3v3mawqzu	44	10	cheaper	cheap	JJR
work_4ezbiswdwvaltiifn3v3mawqzu	44	11	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	44	12	therapies	therapie	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	44	13	lead	lead	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	44	14	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	44	15	confusion	confusion	NN
work_4ezbiswdwvaltiifn3v3mawqzu	44	16	within	within	IN
work_4ezbiswdwvaltiifn3v3mawqzu	44	17	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	44	18	medi-	medi-	NN
work_4ezbiswdwvaltiifn3v3mawqzu	44	19	cal	cal	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	44	20	community	community	NN
work_4ezbiswdwvaltiifn3v3mawqzu	44	21	regarding	regard	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	44	22	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	44	23	efficacy	efficacy	NN
work_4ezbiswdwvaltiifn3v3mawqzu	44	24	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	44	25	new	new	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	44	26	agents	agent	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	44	27	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	45	1	Simply	simply	RB
work_4ezbiswdwvaltiifn3v3mawqzu	45	2	because	because	IN
work_4ezbiswdwvaltiifn3v3mawqzu	45	3	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	45	4	newer	new	JJR
work_4ezbiswdwvaltiifn3v3mawqzu	45	5	medication	medication	NN
work_4ezbiswdwvaltiifn3v3mawqzu	45	6	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	45	7	superior	superior	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	45	8	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	45	9	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	45	10	placebo	placebo	NN
work_4ezbiswdwvaltiifn3v3mawqzu	45	11	does	do	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	45	12	not	not	RB
work_4ezbiswdwvaltiifn3v3mawqzu	45	13	mean	mean	VB
work_4ezbiswdwvaltiifn3v3mawqzu	45	14	that	that	IN
work_4ezbiswdwvaltiifn3v3mawqzu	45	15	it	-PRON-	PRP
work_4ezbiswdwvaltiifn3v3mawqzu	45	16	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	45	17	better	well	JJR
work_4ezbiswdwvaltiifn3v3mawqzu	45	18	than	than	IN
work_4ezbiswdwvaltiifn3v3mawqzu	45	19	traditional	traditional	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	45	20	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	45	21	standard	standard	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	45	22	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	45	23	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	45	24	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	45	25	care	care	NN
work_4ezbiswdwvaltiifn3v3mawqzu	45	26	therapy	therapy	NN
work_4ezbiswdwvaltiifn3v3mawqzu	45	27	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	46	1	To	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	46	2	examine	examine	VB
work_4ezbiswdwvaltiifn3v3mawqzu	46	3	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	46	4	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	46	5	used	use	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	46	6	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	46	7	support	support	VB
work_4ezbiswdwvaltiifn3v3mawqzu	46	8	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	46	9	use	use	NN
work_4ezbiswdwvaltiifn3v3mawqzu	46	10	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	46	11	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	46	12	new	new	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	46	13	class	class	NN
work_4ezbiswdwvaltiifn3v3mawqzu	46	14	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	46	15	medication	medication	NN
work_4ezbiswdwvaltiifn3v3mawqzu	46	16	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	46	17	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	46	18	treatment	treatment	NN
work_4ezbiswdwvaltiifn3v3mawqzu	46	19	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	46	20	atopic	atopic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	46	21	derma-	derma-	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	46	22	titis	titis	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	46	23	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	46	24	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	46	25	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	46	26	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	46	27	combined	combine	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	46	28	data	datum	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	46	29	from	from	IN
work_4ezbiswdwvaltiifn3v3mawqzu	46	30	randomized	randomized	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	46	31	controlled	controlled	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	46	32	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	46	33	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	46	34	determine	determine	VB
work_4ezbiswdwvaltiifn3v3mawqzu	46	35	whether	whether	IN
work_4ezbiswdwvaltiifn3v3mawqzu	46	36	topical	topical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	46	37	pimecrolimus	pimecrolimus	NN
work_4ezbiswdwvaltiifn3v3mawqzu	46	38	was	be	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	46	39	more	more	RBR
work_4ezbiswdwvaltiifn3v3mawqzu	46	40	effective	effective	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	46	41	than	than	IN
work_4ezbiswdwvaltiifn3v3mawqzu	46	42	other	other	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	46	43	treatments	treatment	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	46	44	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	46	45	Ashcroft	Ashcroft	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	46	46	et	et	FW
work_4ezbiswdwvaltiifn3v3mawqzu	46	47	al	al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	46	48	.	.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	46	49	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	46	50	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	46	51	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	46	52	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	47	1	Of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	47	2	11	11	CD
work_4ezbiswdwvaltiifn3v3mawqzu	47	3	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	47	4	using	use	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	47	5	pimecrolimus	pimecrolimus	NN
work_4ezbiswdwvaltiifn3v3mawqzu	47	6	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	47	7	eight	eight	CD
work_4ezbiswdwvaltiifn3v3mawqzu	47	8	compared	compare	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	47	9	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	47	10	drug	drug	NN
work_4ezbiswdwvaltiifn3v3mawqzu	47	11	with	with	IN
work_4ezbiswdwvaltiifn3v3mawqzu	47	12	vehicle	vehicle	NN
work_4ezbiswdwvaltiifn3v3mawqzu	47	13	only	only	RB
work_4ezbiswdwvaltiifn3v3mawqzu	47	14	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	48	1	Strikingly	strikingly	RB
work_4ezbiswdwvaltiifn3v3mawqzu	48	2	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	48	3	none	none	NN
work_4ezbiswdwvaltiifn3v3mawqzu	48	4	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	48	5	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	48	6	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	48	7	includ-	includ-	.
work_4ezbiswdwvaltiifn3v3mawqzu	48	8	ed	ed	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	48	9	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	48	10	comparison	comparison	NN
work_4ezbiswdwvaltiifn3v3mawqzu	48	11	with	with	IN
work_4ezbiswdwvaltiifn3v3mawqzu	48	12	what	what	WP
work_4ezbiswdwvaltiifn3v3mawqzu	48	13	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	48	14	perhaps	perhaps	RB
work_4ezbiswdwvaltiifn3v3mawqzu	48	15	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	48	16	most	most	RBS
work_4ezbiswdwvaltiifn3v3mawqzu	48	17	appropriate	appropriate	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	48	18	active	active	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	48	19	comparator	comparator	NN
work_4ezbiswdwvaltiifn3v3mawqzu	48	20	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	48	21	mild	mild	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	48	22	atopic	atopic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	48	23	dermatitis	dermatitis	NN
work_4ezbiswdwvaltiifn3v3mawqzu	48	24	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	48	25	twice	twice	RB
work_4ezbiswdwvaltiifn3v3mawqzu	48	26	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	48	27	daily	daily	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	48	28	1	1	CD
work_4ezbiswdwvaltiifn3v3mawqzu	48	29	%	%	NN
work_4ezbiswdwvaltiifn3v3mawqzu	48	30	hydrocortisone	hydrocortisone	NN
work_4ezbiswdwvaltiifn3v3mawqzu	48	31	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	49	1	Mirroring	mirror	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	49	2	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	49	3	aprotinin	aprotinin	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	49	4	example	example	NN
work_4ezbiswdwvaltiifn3v3mawqzu	49	5	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	49	6	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	49	7	efficacy	efficacy	NN
work_4ezbiswdwvaltiifn3v3mawqzu	49	8	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	49	9	pimecrolimus	pimecrolimus	NN
work_4ezbiswdwvaltiifn3v3mawqzu	49	10	as	as	IN
work_4ezbiswdwvaltiifn3v3mawqzu	49	11	compared	compare	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	49	12	with	with	IN
work_4ezbiswdwvaltiifn3v3mawqzu	49	13	vehicle	vehicle	NN
work_4ezbiswdwvaltiifn3v3mawqzu	49	14	at	at	IN
work_4ezbiswdwvaltiifn3v3mawqzu	49	15	3	3	CD
work_4ezbiswdwvaltiifn3v3mawqzu	49	16	weeks	week	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	49	17	was	be	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	49	18	evident	evident	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	49	19	after	after	IN
work_4ezbiswdwvaltiifn3v3mawqzu	49	20	completion	completion	NN
work_4ezbiswdwvaltiifn3v3mawqzu	49	21	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	49	22	three	three	CD
work_4ezbiswdwvaltiifn3v3mawqzu	49	23	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	49	24	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	50	1	Although	although	IN
work_4ezbiswdwvaltiifn3v3mawqzu	50	2	additional	additional	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	50	3	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	50	4	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	50	5	sometimes	sometimes	RB
work_4ezbiswdwvaltiifn3v3mawqzu	50	6	required	require	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	50	7	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	50	8	demonstrate	demonstrate	VB
work_4ezbiswdwvaltiifn3v3mawqzu	50	9	efficacy	efficacy	NN
work_4ezbiswdwvaltiifn3v3mawqzu	50	10	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	50	11	differ-	differ-	FW
work_4ezbiswdwvaltiifn3v3mawqzu	50	12	ent	ent	NN
work_4ezbiswdwvaltiifn3v3mawqzu	50	13	groups	group	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	50	14	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	50	15	such	such	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	50	16	as	as	IN
work_4ezbiswdwvaltiifn3v3mawqzu	50	17	adults	adult	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	50	18	versus	versus	IN
work_4ezbiswdwvaltiifn3v3mawqzu	50	19	children	child	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	50	20	or	or	CC
work_4ezbiswdwvaltiifn3v3mawqzu	50	21	different	different	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	50	22	ethnic	ethnic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	50	23	groups	group	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	50	24	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	50	25	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	50	26	government	government	NN
work_4ezbiswdwvaltiifn3v3mawqzu	50	27	drug	drug	NN
work_4ezbiswdwvaltiifn3v3mawqzu	50	28	administrations	administration	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	50	29	may	may	MD
work_4ezbiswdwvaltiifn3v3mawqzu	50	30	require	require	VB
work_4ezbiswdwvaltiifn3v3mawqzu	50	31	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	50	32	repetition	repetition	NN
work_4ezbiswdwvaltiifn3v3mawqzu	50	33	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	50	34	clinical	clinical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	50	35	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	50	36	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	50	37	some	some	DT
work_4ezbiswdwvaltiifn3v3mawqzu	50	38	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	50	39	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	50	40	remaining	remain	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	50	41	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	50	42	could	could	MD
work_4ezbiswdwvaltiifn3v3mawqzu	50	43	be	be	VB
work_4ezbiswdwvaltiifn3v3mawqzu	50	44	viewed	view	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	50	45	as	as	IN
work_4ezbiswdwvaltiifn3v3mawqzu	50	46	unnecessary	unnecessary	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	50	47	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	50	48	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	50	49	waste	waste	NN
work_4ezbiswdwvaltiifn3v3mawqzu	50	50	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	50	51	research	research	NN
work_4ezbiswdwvaltiifn3v3mawqzu	50	52	resources	resource	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	50	53	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	51	1	Further	further	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	51	2	studies	study	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	51	3	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	51	4	not	not	RB
work_4ezbiswdwvaltiifn3v3mawqzu	51	5	needed	need	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	51	6	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	51	7	establish	establish	VB
work_4ezbiswdwvaltiifn3v3mawqzu	51	8	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	51	9	effectiveness	effectiveness	NN
work_4ezbiswdwvaltiifn3v3mawqzu	51	10	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	51	11	pimecrolimus	pimecrolimus	NN
work_4ezbiswdwvaltiifn3v3mawqzu	51	12	as	as	IN
work_4ezbiswdwvaltiifn3v3mawqzu	51	13	compared	compare	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	51	14	with	with	IN
work_4ezbiswdwvaltiifn3v3mawqzu	51	15	placebo	placebo	NN
work_4ezbiswdwvaltiifn3v3mawqzu	51	16	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	52	1	Limitations	limitation	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	52	2	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	52	3	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	52	4	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	52	5	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	53	1	Like	like	IN
work_4ezbiswdwvaltiifn3v3mawqzu	53	2	all	all	DT
work_4ezbiswdwvaltiifn3v3mawqzu	53	3	scientific	scientific	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	53	4	research	research	NN
work_4ezbiswdwvaltiifn3v3mawqzu	53	5	methodologies	methodology	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	53	6	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	53	7	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	53	8	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	53	9	have	have	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	53	10	limitations	limitation	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	53	11	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	54	1	Extensive	extensive	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	54	2	labor	labor	NN
work_4ezbiswdwvaltiifn3v3mawqzu	54	3	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	54	4	involved	involve	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	54	5	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	54	6	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	54	7	creation	creation	NN
work_4ezbiswdwvaltiifn3v3mawqzu	54	8	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	54	9	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	54	10	quality	quality	NN
work_4ezbiswdwvaltiifn3v3mawqzu	54	11	sys-	sys-	NN
work_4ezbiswdwvaltiifn3v3mawqzu	54	12	tematic	tematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	54	13	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	54	14	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	54	15	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	54	16	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	54	17	finished	finished	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	54	18	product	product	NN
work_4ezbiswdwvaltiifn3v3mawqzu	54	19	can	can	MD
work_4ezbiswdwvaltiifn3v3mawqzu	54	20	be	be	VB
work_4ezbiswdwvaltiifn3v3mawqzu	54	21	cumbersome	cumbersome	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	54	22	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	54	23	read	read	VB
work_4ezbiswdwvaltiifn3v3mawqzu	54	24	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	54	25	those	those	DT
work_4ezbiswdwvaltiifn3v3mawqzu	54	26	not	not	RB
work_4ezbiswdwvaltiifn3v3mawqzu	54	27	familiar	familiar	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	54	28	with	with	IN
work_4ezbiswdwvaltiifn3v3mawqzu	54	29	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	54	30	methodology	methodology	NN
work_4ezbiswdwvaltiifn3v3mawqzu	54	31	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	55	1	One	one	CD
work_4ezbiswdwvaltiifn3v3mawqzu	55	2	study	study	NN
work_4ezbiswdwvaltiifn3v3mawqzu	55	3	reported	report	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	55	4	that	that	IN
work_4ezbiswdwvaltiifn3v3mawqzu	55	5	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	55	6	median	median	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	55	7	length	length	NN
work_4ezbiswdwvaltiifn3v3mawqzu	55	8	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	55	9	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	55	10	Cochrane	Cochrane	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	55	11	system-	system-	NN
work_4ezbiswdwvaltiifn3v3mawqzu	55	12	atic	atic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	55	13	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	55	14	was	be	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	55	15	15	15	CD
work_4ezbiswdwvaltiifn3v3mawqzu	55	16	printed	print	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	55	17	pages	page	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	55	18	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	55	19	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	55	20	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	55	21	substantial	substantial	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	55	22	number	number	NN
work_4ezbiswdwvaltiifn3v3mawqzu	55	23	exceeded	exceed	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	55	24	30	30	CD
work_4ezbiswdwvaltiifn3v3mawqzu	55	25	pages	page	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	55	26	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	55	27	Johansen	Johansen	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	55	28	et	et	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	55	29	al	al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	55	30	.	.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	55	31	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	55	32	2001	2001	CD
work_4ezbiswdwvaltiifn3v3mawqzu	55	33	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	55	34	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	56	1	Funding	fund	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	56	2	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	56	3	these	these	DT
work_4ezbiswdwvaltiifn3v3mawqzu	56	4	time	time	NN
work_4ezbiswdwvaltiifn3v3mawqzu	56	5	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	56	6	consuming	consume	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	56	7	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	56	8	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	56	9	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	56	10	currently	currently	RB
work_4ezbiswdwvaltiifn3v3mawqzu	56	11	limited	limit	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	56	12	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	56	13	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	56	14	most	most	JJS
work_4ezbiswdwvaltiifn3v3mawqzu	56	15	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	56	16	done	do	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	56	17	by	by	IN
work_4ezbiswdwvaltiifn3v3mawqzu	56	18	volunteers	volunteer	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	56	19	interested	interested	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	56	20	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	56	21	performing	perform	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	56	22	them	-PRON-	PRP
work_4ezbiswdwvaltiifn3v3mawqzu	56	23	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	57	1	Access	access	NN
work_4ezbiswdwvaltiifn3v3mawqzu	57	2	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	57	3	quality	quality	NN
work_4ezbiswdwvaltiifn3v3mawqzu	57	4	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	57	5	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	57	6	limited	limit	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	57	7	too	too	RB
work_4ezbiswdwvaltiifn3v3mawqzu	57	8	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	57	9	as	as	IN
work_4ezbiswdwvaltiifn3v3mawqzu	57	10	databases	database	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	57	11	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	57	12	sys-	sys-	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	57	13	tematic	tematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	57	14	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	57	15	like	like	IN
work_4ezbiswdwvaltiifn3v3mawqzu	57	16	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	57	17	Cochrane	Cochrane	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	57	18	Database	Database	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	57	19	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	57	20	available	available	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	57	21	online	online	RB
work_4ezbiswdwvaltiifn3v3mawqzu	57	22	only	only	RB
work_4ezbiswdwvaltiifn3v3mawqzu	57	23	by	by	IN
work_4ezbiswdwvaltiifn3v3mawqzu	57	24	subscription	subscription	NN
work_4ezbiswdwvaltiifn3v3mawqzu	57	25	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	57	26	some	some	DT
work_4ezbiswdwvaltiifn3v3mawqzu	57	27	countries	country	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	57	28	that	that	WDT
work_4ezbiswdwvaltiifn3v3mawqzu	57	29	have	have	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	57	30	not	not	RB
work_4ezbiswdwvaltiifn3v3mawqzu	57	31	arranged	arrange	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	57	32	national	national	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	57	33	procurement	procurement	NN
work_4ezbiswdwvaltiifn3v3mawqzu	57	34	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	58	1	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	58	2	methodology	methodology	NN
work_4ezbiswdwvaltiifn3v3mawqzu	58	3	associated	associate	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	58	4	with	with	IN
work_4ezbiswdwvaltiifn3v3mawqzu	58	5	conducting	conduct	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	58	6	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	58	7	system-	system-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	58	8	atic	atic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	58	9	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	58	10	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	58	11	complex	complex	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	58	12	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	58	13	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	58	14	expertise	expertise	NN
work_4ezbiswdwvaltiifn3v3mawqzu	58	15	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	58	16	required	require	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	58	17	at	at	IN
work_4ezbiswdwvaltiifn3v3mawqzu	58	18	each	each	DT
work_4ezbiswdwvaltiifn3v3mawqzu	58	19	step	step	NN
work_4ezbiswdwvaltiifn3v3mawqzu	58	20	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	58	21	from	from	IN
work_4ezbiswdwvaltiifn3v3mawqzu	58	22	question	question	NN
work_4ezbiswdwvaltiifn3v3mawqzu	58	23	creation	creation	NN
work_4ezbiswdwvaltiifn3v3mawqzu	58	24	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	58	25	data	datum	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	58	26	collection	collection	NN
work_4ezbiswdwvaltiifn3v3mawqzu	58	27	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	58	28	analysis	analysis	NN
work_4ezbiswdwvaltiifn3v3mawqzu	58	29	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	58	30	interpretation	interpretation	NN
work_4ezbiswdwvaltiifn3v3mawqzu	58	31	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	59	1	Errors	error	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	59	2	can	can	MD
work_4ezbiswdwvaltiifn3v3mawqzu	59	3	occur	occur	VB
work_4ezbiswdwvaltiifn3v3mawqzu	59	4	at	at	IN
work_4ezbiswdwvaltiifn3v3mawqzu	59	5	any	any	DT
work_4ezbiswdwvaltiifn3v3mawqzu	59	6	step	step	NN
work_4ezbiswdwvaltiifn3v3mawqzu	59	7	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	59	8	this	this	DT
work_4ezbiswdwvaltiifn3v3mawqzu	59	9	complex	complex	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	59	10	process	process	NN
work_4ezbiswdwvaltiifn3v3mawqzu	59	11	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	59	12	potentially	potentially	RB
work_4ezbiswdwvaltiifn3v3mawqzu	59	13	can	can	MD
work_4ezbiswdwvaltiifn3v3mawqzu	59	14	lead	lead	VB
work_4ezbiswdwvaltiifn3v3mawqzu	59	15	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	59	16	meaningless	meaningless	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	59	17	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	59	18	misin-	misin-	NN
work_4ezbiswdwvaltiifn3v3mawqzu	59	19	terpreted	terprete	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	59	20	data	datum	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	59	21	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	60	1	Disease-	disease-	NN
work_4ezbiswdwvaltiifn3v3mawqzu	60	2	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	60	3	intervention	intervention	NN
work_4ezbiswdwvaltiifn3v3mawqzu	60	4	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	60	5	definition	definition	NN
work_4ezbiswdwvaltiifn3v3mawqzu	60	6	method-	method-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	60	7	ology	ology	NN
work_4ezbiswdwvaltiifn3v3mawqzu	60	8	used	use	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	60	9	prior	prior	RB
work_4ezbiswdwvaltiifn3v3mawqzu	60	10	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	60	11	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	60	12	collection	collection	NN
work_4ezbiswdwvaltiifn3v3mawqzu	60	13	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	60	14	analysis	analysis	NN
work_4ezbiswdwvaltiifn3v3mawqzu	60	15	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	60	16	data	datum	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	60	17	can	can	MD
work_4ezbiswdwvaltiifn3v3mawqzu	60	18	greatly	greatly	RB
work_4ezbiswdwvaltiifn3v3mawqzu	60	19	influence	influence	VB
work_4ezbiswdwvaltiifn3v3mawqzu	60	20	which	which	WDT
work_4ezbiswdwvaltiifn3v3mawqzu	60	21	studies	study	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	60	22	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	60	23	ultimately	ultimately	RB
work_4ezbiswdwvaltiifn3v3mawqzu	60	24	included	include	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	60	25	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	61	1	EDITORIAL	EDITORIAL	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	61	2	©	©	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	61	3	2006	2006	CD
work_4ezbiswdwvaltiifn3v3mawqzu	61	4	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	61	5	Society	Society	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	61	6	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	61	7	Investigative	Investigative	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	61	8	Dermatology	Dermatology	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	61	9	www.jidonline.org	www.jidonline.org	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	61	10	2359	2359	CD
work_4ezbiswdwvaltiifn3v3mawqzu	61	11	EDITORIAL	EDITORIAL	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	61	12	Systematic	Systematic	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	61	13	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	61	14	questions	question	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	61	15	must	must	MD
work_4ezbiswdwvaltiifn3v3mawqzu	61	16	be	be	VB
work_4ezbiswdwvaltiifn3v3mawqzu	61	17	designed	design	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	61	18	carefully	carefully	RB
work_4ezbiswdwvaltiifn3v3mawqzu	61	19	so	so	IN
work_4ezbiswdwvaltiifn3v3mawqzu	61	20	that	that	IN
work_4ezbiswdwvaltiifn3v3mawqzu	61	21	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	61	22	greatest	great	JJS
work_4ezbiswdwvaltiifn3v3mawqzu	61	23	number	number	NN
work_4ezbiswdwvaltiifn3v3mawqzu	61	24	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	61	25	appropriate	appropriate	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	61	26	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	61	27	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	61	28	included	include	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	61	29	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	61	30	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	61	31	final	final	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	61	32	analysis	analysis	NN
work_4ezbiswdwvaltiifn3v3mawqzu	61	33	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	62	1	Therefore	therefore	RB
work_4ezbiswdwvaltiifn3v3mawqzu	62	2	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	62	3	quality	quality	NN
work_4ezbiswdwvaltiifn3v3mawqzu	62	4	control	control	NN
work_4ezbiswdwvaltiifn3v3mawqzu	62	5	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	62	6	essential	essential	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	62	7	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	63	1	A	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	63	2	common	common	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	63	3	concern	concern	NN
work_4ezbiswdwvaltiifn3v3mawqzu	63	4	expressed	express	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	63	5	by	by	IN
work_4ezbiswdwvaltiifn3v3mawqzu	63	6	those	those	DT
work_4ezbiswdwvaltiifn3v3mawqzu	63	7	familiar	familiar	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	63	8	with	with	IN
work_4ezbiswdwvaltiifn3v3mawqzu	63	9	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	63	10	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	63	11	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	63	12	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	63	13	effect	effect	NN
work_4ezbiswdwvaltiifn3v3mawqzu	63	14	heterogeneity	heterogeneity	NN
work_4ezbiswdwvaltiifn3v3mawqzu	63	15	may	may	MD
work_4ezbiswdwvaltiifn3v3mawqzu	63	16	have	have	VB
work_4ezbiswdwvaltiifn3v3mawqzu	63	17	on	on	IN
work_4ezbiswdwvaltiifn3v3mawqzu	63	18	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	63	19	outcomes	outcome	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	63	20	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	64	1	Heterogeneity	heterogeneity	NN
work_4ezbiswdwvaltiifn3v3mawqzu	64	2	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	64	3	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	64	4	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	64	5	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	64	6	can	can	MD
work_4ezbiswdwvaltiifn3v3mawqzu	64	7	be	be	VB
work_4ezbiswdwvaltiifn3v3mawqzu	64	8	described	describe	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	64	9	as	as	IN
work_4ezbiswdwvaltiifn3v3mawqzu	64	10	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	64	11	measure	measure	NN
work_4ezbiswdwvaltiifn3v3mawqzu	64	12	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	64	13	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	64	14	intervention	intervention	NN
work_4ezbiswdwvaltiifn3v3mawqzu	64	15	variability	variability	NN
work_4ezbiswdwvaltiifn3v3mawqzu	64	16	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	64	17	study	study	NN
work_4ezbiswdwvaltiifn3v3mawqzu	64	18	variation	variation	NN
work_4ezbiswdwvaltiifn3v3mawqzu	64	19	that	that	WDT
work_4ezbiswdwvaltiifn3v3mawqzu	64	20	exist	exist	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	64	21	among	among	IN
work_4ezbiswdwvaltiifn3v3mawqzu	64	22	included	include	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	64	23	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	64	24	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	65	1	It	-PRON-	PRP
work_4ezbiswdwvaltiifn3v3mawqzu	65	2	can	can	MD
work_4ezbiswdwvaltiifn3v3mawqzu	65	3	be	be	VB
work_4ezbiswdwvaltiifn3v3mawqzu	65	4	dif-	dif-	RB
work_4ezbiswdwvaltiifn3v3mawqzu	65	5	ficult	ficult	NN
work_4ezbiswdwvaltiifn3v3mawqzu	65	6	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	65	7	know	know	VB
work_4ezbiswdwvaltiifn3v3mawqzu	65	8	when	when	WRB
work_4ezbiswdwvaltiifn3v3mawqzu	65	9	it	-PRON-	PRP
work_4ezbiswdwvaltiifn3v3mawqzu	65	10	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	65	11	appropriate	appropriate	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	65	12	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	65	13	combine	combine	VB
work_4ezbiswdwvaltiifn3v3mawqzu	65	14	results	result	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	65	15	from	from	IN
work_4ezbiswdwvaltiifn3v3mawqzu	65	16	included	include	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	65	17	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	65	18	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	66	1	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	66	2	decision	decision	NN
work_4ezbiswdwvaltiifn3v3mawqzu	66	3	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	66	4	do	do	VB
work_4ezbiswdwvaltiifn3v3mawqzu	66	5	so	so	RB
work_4ezbiswdwvaltiifn3v3mawqzu	66	6	should	should	MD
work_4ezbiswdwvaltiifn3v3mawqzu	66	7	rest	rest	VB
work_4ezbiswdwvaltiifn3v3mawqzu	66	8	on	on	IN
work_4ezbiswdwvaltiifn3v3mawqzu	66	9	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	66	10	solid	solid	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	66	11	understanding	understanding	NN
work_4ezbiswdwvaltiifn3v3mawqzu	66	12	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	66	13	trial	trial	NN
work_4ezbiswdwvaltiifn3v3mawqzu	66	14	heterogeneity	heterogeneity	NN
work_4ezbiswdwvaltiifn3v3mawqzu	66	15	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	67	1	A	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	67	2	critical	critical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	67	3	eye	eye	NN
work_4ezbiswdwvaltiifn3v3mawqzu	67	4	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	67	5	needed	need	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	67	6	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	67	7	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	67	8	interpretation	interpretation	NN
work_4ezbiswdwvaltiifn3v3mawqzu	67	9	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	67	10	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	67	11	results	result	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	67	12	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	67	13	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	67	14	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	67	15	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	67	16	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	67	17	one	one	NN
work_4ezbiswdwvaltiifn3v3mawqzu	67	18	that	that	WDT
work_4ezbiswdwvaltiifn3v3mawqzu	67	19	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	67	20	better	well	RBR
work_4ezbiswdwvaltiifn3v3mawqzu	67	21	able	able	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	67	22	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	67	23	focus	focus	VB
work_4ezbiswdwvaltiifn3v3mawqzu	67	24	on	on	IN
work_4ezbiswdwvaltiifn3v3mawqzu	67	25	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	67	26	results	result	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	67	27	by	by	IN
work_4ezbiswdwvaltiifn3v3mawqzu	67	28	looking	look	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	67	29	through	through	IN
work_4ezbiswdwvaltiifn3v3mawqzu	67	30	sometimes	sometimes	RB
work_4ezbiswdwvaltiifn3v3mawqzu	67	31	complicated	complicate	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	67	32	methodology	methodology	NN
work_4ezbiswdwvaltiifn3v3mawqzu	67	33	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	68	1	To	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	68	2	be	be	VB
work_4ezbiswdwvaltiifn3v3mawqzu	68	3	representative	representative	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	68	4	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	68	5	all	all	DT
work_4ezbiswdwvaltiifn3v3mawqzu	68	6	available	available	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	68	7	evidence	evidence	NN
work_4ezbiswdwvaltiifn3v3mawqzu	68	8	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	68	9	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	68	10	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	68	11	must	must	MD
work_4ezbiswdwvaltiifn3v3mawqzu	68	12	be	be	VB
work_4ezbiswdwvaltiifn3v3mawqzu	68	13	periodically	periodically	RB
work_4ezbiswdwvaltiifn3v3mawqzu	68	14	updated	update	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	68	15	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	69	1	Updating	updating	NN
work_4ezbiswdwvaltiifn3v3mawqzu	69	2	has	have	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	69	3	been	be	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	69	4	defined	define	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	69	5	as	as	IN
work_4ezbiswdwvaltiifn3v3mawqzu	69	6	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	69	7	discrete	discrete	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	69	8	event	event	NN
work_4ezbiswdwvaltiifn3v3mawqzu	69	9	with	with	IN
work_4ezbiswdwvaltiifn3v3mawqzu	69	10	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	69	11	aim	aim	NN
work_4ezbiswdwvaltiifn3v3mawqzu	69	12	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	69	13	searching	search	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	69	14	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	69	15	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	69	16	identifying	identify	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	69	17	new	new	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	69	18	evidence	evidence	NN
work_4ezbiswdwvaltiifn3v3mawqzu	69	19	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	69	20	incorporate	incorporate	VB
work_4ezbiswdwvaltiifn3v3mawqzu	69	21	into	into	IN
work_4ezbiswdwvaltiifn3v3mawqzu	69	22	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	69	23	previously	previously	RB
work_4ezbiswdwvaltiifn3v3mawqzu	69	24	completed	complete	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	69	25	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	69	26	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	69	27	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	69	28	Moher	Moher	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	69	29	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	69	30	Tsertsvadze	Tsertsvadze	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	69	31	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	69	32	2006	2006	CD
work_4ezbiswdwvaltiifn3v3mawqzu	69	33	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	69	34	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	70	1	It	-PRON-	PRP
work_4ezbiswdwvaltiifn3v3mawqzu	70	2	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	70	3	also	also	RB
work_4ezbiswdwvaltiifn3v3mawqzu	70	4	often	often	RB
work_4ezbiswdwvaltiifn3v3mawqzu	70	5	difficult	difficult	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	70	6	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	70	7	determine	determine	VB
work_4ezbiswdwvaltiifn3v3mawqzu	70	8	when	when	WRB
work_4ezbiswdwvaltiifn3v3mawqzu	70	9	it	-PRON-	PRP
work_4ezbiswdwvaltiifn3v3mawqzu	70	10	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	70	11	appropriate	appropriate	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	70	12	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	70	13	update	update	VB
work_4ezbiswdwvaltiifn3v3mawqzu	70	14	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	70	15	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	70	16	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	70	17	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	70	18	as	as	IN
work_4ezbiswdwvaltiifn3v3mawqzu	70	19	this	this	DT
work_4ezbiswdwvaltiifn3v3mawqzu	70	20	decision	decision	NN
work_4ezbiswdwvaltiifn3v3mawqzu	70	21	must	must	MD
work_4ezbiswdwvaltiifn3v3mawqzu	70	22	rest	rest	VB
work_4ezbiswdwvaltiifn3v3mawqzu	70	23	on	on	IN
work_4ezbiswdwvaltiifn3v3mawqzu	70	24	an	an	DT
work_4ezbiswdwvaltiifn3v3mawqzu	70	25	analysis	analysis	NN
work_4ezbiswdwvaltiifn3v3mawqzu	70	26	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	70	27	information	information	NN
work_4ezbiswdwvaltiifn3v3mawqzu	70	28	evolution	evolution	NN
work_4ezbiswdwvaltiifn3v3mawqzu	70	29	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	70	30	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	70	31	quantity	quantity	NN
work_4ezbiswdwvaltiifn3v3mawqzu	70	32	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	70	33	avail-	avail-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	70	34	able	able	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	70	35	studies	study	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	70	36	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	71	1	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	71	2	changing	change	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	71	3	biomedical	biomedical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	71	4	environment	environment	NN
work_4ezbiswdwvaltiifn3v3mawqzu	71	5	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	71	6	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	71	7	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	71	8	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	72	1	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	72	2	number	number	NN
work_4ezbiswdwvaltiifn3v3mawqzu	72	3	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	72	4	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	72	5	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	72	6	has	have	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	72	7	grown	grow	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	72	8	exponentially	exponentially	RB
work_4ezbiswdwvaltiifn3v3mawqzu	72	9	since	since	IN
work_4ezbiswdwvaltiifn3v3mawqzu	72	10	1975	1975	CD
work_4ezbiswdwvaltiifn3v3mawqzu	72	11	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	72	12	Egger	Egger	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	72	13	et	et	FW
work_4ezbiswdwvaltiifn3v3mawqzu	72	14	al	al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	72	15	.	.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	72	16	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	72	17	2001	2001	CD
work_4ezbiswdwvaltiifn3v3mawqzu	72	18	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	72	19	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	72	20	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	72	21	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	72	22	grow-	grow-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	72	23	ing	ing	NN
work_4ezbiswdwvaltiifn3v3mawqzu	72	24	number	number	NN
work_4ezbiswdwvaltiifn3v3mawqzu	72	25	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	72	26	agencies	agency	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	72	27	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	72	28	performing	perform	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	72	29	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	72	30	using	use	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	72	31	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	72	32	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	72	33	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	72	34	Atkins	Atkins	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	72	35	et	et	FW
work_4ezbiswdwvaltiifn3v3mawqzu	72	36	al	al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	72	37	.	.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	72	38	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	72	39	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	72	40	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	72	41	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	73	1	Systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	73	2	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	73	3	now	now	RB
work_4ezbiswdwvaltiifn3v3mawqzu	73	4	have	have	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	73	5	an	an	DT
work_4ezbiswdwvaltiifn3v3mawqzu	73	6	increased	increase	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	73	7	presence	presence	NN
work_4ezbiswdwvaltiifn3v3mawqzu	73	8	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	73	9	policy	policy	NN
work_4ezbiswdwvaltiifn3v3mawqzu	73	10	at	at	IN
work_4ezbiswdwvaltiifn3v3mawqzu	73	11	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	73	12	government	government	NN
work_4ezbiswdwvaltiifn3v3mawqzu	73	13	level	level	NN
work_4ezbiswdwvaltiifn3v3mawqzu	73	14	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	73	15	with	with	IN
work_4ezbiswdwvaltiifn3v3mawqzu	73	16	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	73	17	influencing	influence	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	73	18	coverage	coverage	NN
work_4ezbiswdwvaltiifn3v3mawqzu	73	19	decisions	decision	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	73	20	made	make	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	73	21	by	by	IN
work_4ezbiswdwvaltiifn3v3mawqzu	73	22	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	73	23	Centers	Centers	NNPS
work_4ezbiswdwvaltiifn3v3mawqzu	73	24	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	73	25	Medicare	Medicare	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	73	26	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	73	27	Medicaid	Medicaid	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	73	28	Services	Services	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	73	29	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	73	30	consensus	consensus	NN
work_4ezbiswdwvaltiifn3v3mawqzu	73	31	conferenc-	conferenc-	NN
work_4ezbiswdwvaltiifn3v3mawqzu	73	32	es	es	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	73	33	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	73	34	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	73	35	other	other	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	73	36	policy	policy	NN
work_4ezbiswdwvaltiifn3v3mawqzu	73	37	initiatives	initiative	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	73	38	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	73	39	Atkins	Atkins	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	73	40	et	et	FW
work_4ezbiswdwvaltiifn3v3mawqzu	73	41	al	al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	73	42	.	.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	73	43	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	73	44	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	73	45	;	;	:
work_4ezbiswdwvaltiifn3v3mawqzu	73	46	Tugwell	Tugwell	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	73	47	et	et	FW
work_4ezbiswdwvaltiifn3v3mawqzu	73	48	al	al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	73	49	.	.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	73	50	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	73	51	2006b	2006b	CD
work_4ezbiswdwvaltiifn3v3mawqzu	73	52	;	;	:
work_4ezbiswdwvaltiifn3v3mawqzu	73	53	Moynihan	Moynihan	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	73	54	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	73	55	2004	2004	CD
work_4ezbiswdwvaltiifn3v3mawqzu	73	56	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	73	57	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	74	1	Through	through	IN
work_4ezbiswdwvaltiifn3v3mawqzu	74	2	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	74	3	creation	creation	NN
work_4ezbiswdwvaltiifn3v3mawqzu	74	4	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	74	5	an	an	DT
work_4ezbiswdwvaltiifn3v3mawqzu	74	6	Equity	Equity	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	74	7	Group	Group	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	74	8	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	74	9	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	74	10	Campbell	Campbell	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	74	11	Collaboration	Collaboration	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	74	12	Equity	Equity	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	74	13	Methods	Methods	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	74	14	Group	Group	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	74	15	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	74	16	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	74	17	Cochrane	Cochrane	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	74	18	Collaboration	Collaboration	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	74	19	Equity	Equity	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	74	20	Field	Field	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	74	21	aim	aim	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	74	22	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	74	23	use	use	VB
work_4ezbiswdwvaltiifn3v3mawqzu	74	24	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	74	25	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	74	26	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	74	27	improve	improve	VB
work_4ezbiswdwvaltiifn3v3mawqzu	74	28	health	health	NN
work_4ezbiswdwvaltiifn3v3mawqzu	74	29	disparities	disparity	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	74	30	world-	world-	VB
work_4ezbiswdwvaltiifn3v3mawqzu	74	31	wide	wide	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	74	32	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	74	33	Tugwell	Tugwell	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	74	34	et	et	FW
work_4ezbiswdwvaltiifn3v3mawqzu	74	35	al	al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	74	36	.	.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	74	37	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	74	38	2006a	2006a	CD
work_4ezbiswdwvaltiifn3v3mawqzu	74	39	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	74	40	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	75	1	Systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	75	2	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	75	3	epitomize	epitomize	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	75	4	evidence	evidence	NN
work_4ezbiswdwvaltiifn3v3mawqzu	75	5	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	75	6	based	base	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	75	7	medicine	medicine	NN
work_4ezbiswdwvaltiifn3v3mawqzu	75	8	;	;	:
work_4ezbiswdwvaltiifn3v3mawqzu	75	9	they	-PRON-	PRP
work_4ezbiswdwvaltiifn3v3mawqzu	75	10	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	75	11	regarded	regard	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	75	12	by	by	IN
work_4ezbiswdwvaltiifn3v3mawqzu	75	13	some	some	DT
work_4ezbiswdwvaltiifn3v3mawqzu	75	14	as	as	IN
work_4ezbiswdwvaltiifn3v3mawqzu	75	15	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	75	16	pinnacle	pinnacle	NN
work_4ezbiswdwvaltiifn3v3mawqzu	75	17	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	75	18	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	75	19	evidence	evidence	NN
work_4ezbiswdwvaltiifn3v3mawqzu	75	20	hierarchy	hierarchy	NN
work_4ezbiswdwvaltiifn3v3mawqzu	75	21	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	75	22	Guyatt	Guyatt	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	75	23	et	et	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	75	24	al	al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	75	25	.	.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	75	26	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	75	27	1995	1995	CD
work_4ezbiswdwvaltiifn3v3mawqzu	75	28	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	75	29	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	75	30	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	75	31	more	more	RBR
work_4ezbiswdwvaltiifn3v3mawqzu	75	32	cited	cited	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	75	33	than	than	IN
work_4ezbiswdwvaltiifn3v3mawqzu	75	34	any	any	DT
work_4ezbiswdwvaltiifn3v3mawqzu	75	35	other	other	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	75	36	study	study	NN
work_4ezbiswdwvaltiifn3v3mawqzu	75	37	design	design	NN
work_4ezbiswdwvaltiifn3v3mawqzu	75	38	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	75	39	Patsopoulos	Patsopoulos	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	75	40	et	et	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	75	41	al	al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	75	42	.	.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	75	43	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	75	44	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	75	45	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	75	46	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	76	1	Weighing	weigh	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	76	2	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	76	3	pros	pro	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	76	4	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	76	5	cons	con	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	76	6	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	76	7	should	should	MD
work_4ezbiswdwvaltiifn3v3mawqzu	76	8	dermatology	dermatology	VB
work_4ezbiswdwvaltiifn3v3mawqzu	76	9	jour-	jour-	NN
work_4ezbiswdwvaltiifn3v3mawqzu	76	10	nals	nal	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	76	11	insist	insist	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	76	12	on	on	IN
work_4ezbiswdwvaltiifn3v3mawqzu	76	13	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	76	14	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	76	15	?	?	.
work_4ezbiswdwvaltiifn3v3mawqzu	77	1	Using	use	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	77	2	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	77	3	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	77	4	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	77	5	link	link	VB
work_4ezbiswdwvaltiifn3v3mawqzu	77	6	past	past	RB
work_4ezbiswdwvaltiifn3v3mawqzu	77	7	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	77	8	present	present	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	77	9	research	research	NN
work_4ezbiswdwvaltiifn3v3mawqzu	77	10	improves	improve	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	77	11	study	study	NN
work_4ezbiswdwvaltiifn3v3mawqzu	77	12	quality	quality	NN
work_4ezbiswdwvaltiifn3v3mawqzu	77	13	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	77	14	effectiveness	effectiveness	NN
work_4ezbiswdwvaltiifn3v3mawqzu	77	15	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	77	16	may	may	MD
work_4ezbiswdwvaltiifn3v3mawqzu	77	17	save	save	VB
work_4ezbiswdwvaltiifn3v3mawqzu	77	18	lives	life	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	77	19	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	77	20	resources	resource	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	77	21	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	77	22	but	but	CC
work_4ezbiswdwvaltiifn3v3mawqzu	77	23	extensive	extensive	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	77	24	labor	labor	NN
work_4ezbiswdwvaltiifn3v3mawqzu	77	25	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	77	26	involved	involve	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	77	27	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	77	28	performing	perform	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	77	29	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	77	30	publishing	publishing	NN
work_4ezbiswdwvaltiifn3v3mawqzu	77	31	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	77	32	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	77	33	updating	update	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	77	34	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	77	35	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	77	36	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	77	37	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	78	1	This	this	DT
work_4ezbiswdwvaltiifn3v3mawqzu	78	2	extra	extra	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	78	3	work	work	NN
work_4ezbiswdwvaltiifn3v3mawqzu	78	4	would	would	MD
work_4ezbiswdwvaltiifn3v3mawqzu	78	5	especially	especially	RB
work_4ezbiswdwvaltiifn3v3mawqzu	78	6	be	be	VB
work_4ezbiswdwvaltiifn3v3mawqzu	78	7	noticeable	noticeable	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	78	8	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	78	9	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	78	10	field	field	NN
work_4ezbiswdwvaltiifn3v3mawqzu	78	11	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	78	12	dermatology	dermatology	NN
work_4ezbiswdwvaltiifn3v3mawqzu	78	13	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	78	14	where	where	WRB
work_4ezbiswdwvaltiifn3v3mawqzu	78	15	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	78	16	numbers	number	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	78	17	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	78	18	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	78	19	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	78	20	published	publish	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	78	21	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	78	22	date	date	NN
work_4ezbiswdwvaltiifn3v3mawqzu	78	23	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	78	24	few	few	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	78	25	—	—	:
work_4ezbiswdwvaltiifn3v3mawqzu	78	26	only	only	RB
work_4ezbiswdwvaltiifn3v3mawqzu	78	27	3	3	CD
work_4ezbiswdwvaltiifn3v3mawqzu	78	28	%	%	NN
work_4ezbiswdwvaltiifn3v3mawqzu	78	29	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	78	30	all	all	DT
work_4ezbiswdwvaltiifn3v3mawqzu	78	31	Cochrane	Cochrane	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	78	32	Reviews	Reviews	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	78	33	from	from	IN
work_4ezbiswdwvaltiifn3v3mawqzu	78	34	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	78	35	search	search	NN
work_4ezbiswdwvaltiifn3v3mawqzu	78	36	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	78	37	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	78	38	Cochrane	Cochrane	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	78	39	Database	Database	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	78	40	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	78	41	Systematic	Systematic	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	78	42	Reviews	Reviews	NNPS
work_4ezbiswdwvaltiifn3v3mawqzu	78	43	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	78	44	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	78	45	Database	Database	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	78	46	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	78	47	Abstracts	Abstracts	NNPS
work_4ezbiswdwvaltiifn3v3mawqzu	78	48	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	78	49	Reviews	Reviews	NNPS
work_4ezbiswdwvaltiifn3v3mawqzu	78	50	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	78	51	Effectiveness	Effectiveness	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	78	52	were	be	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	78	53	deemed	deem	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	78	54	relevant	relevant	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	78	55	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	78	56	dermatol-	dermatol-	XX
work_4ezbiswdwvaltiifn3v3mawqzu	78	57	ogy	ogy	NN
work_4ezbiswdwvaltiifn3v3mawqzu	78	58	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	78	59	Parker	Parker	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	78	60	et	et	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	78	61	al	al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	78	62	.	.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	78	63	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	78	64	2004	2004	CD
work_4ezbiswdwvaltiifn3v3mawqzu	78	65	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	78	66	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	79	1	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	79	2	requirement	requirement	NN
work_4ezbiswdwvaltiifn3v3mawqzu	79	3	that	that	IN
work_4ezbiswdwvaltiifn3v3mawqzu	79	4	all	all	DT
work_4ezbiswdwvaltiifn3v3mawqzu	79	5	new	new	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	79	6	studies	study	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	79	7	be	be	VB
work_4ezbiswdwvaltiifn3v3mawqzu	79	8	preceded	precede	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	79	9	by	by	IN
work_4ezbiswdwvaltiifn3v3mawqzu	79	10	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	79	11	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	79	12	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	79	13	also	also	RB
work_4ezbiswdwvaltiifn3v3mawqzu	79	14	creates	create	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	79	15	extra	extra	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	79	16	work	work	NN
work_4ezbiswdwvaltiifn3v3mawqzu	79	17	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	79	18	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	79	19	journals	journal	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	79	20	that	that	WDT
work_4ezbiswdwvaltiifn3v3mawqzu	79	21	must	must	MD
work_4ezbiswdwvaltiifn3v3mawqzu	79	22	ensure	ensure	VB
work_4ezbiswdwvaltiifn3v3mawqzu	79	23	this	this	DT
work_4ezbiswdwvaltiifn3v3mawqzu	79	24	before	before	IN
work_4ezbiswdwvaltiifn3v3mawqzu	79	25	publication	publication	NN
work_4ezbiswdwvaltiifn3v3mawqzu	79	26	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	79	27	new	new	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	79	28	information	information	NN
work_4ezbiswdwvaltiifn3v3mawqzu	79	29	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	80	1	Given	give	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	80	2	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	80	3	paucity	paucity	NN
work_4ezbiswdwvaltiifn3v3mawqzu	80	4	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	80	5	high	high	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	80	6	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	80	7	quality	quality	NN
work_4ezbiswdwvaltiifn3v3mawqzu	80	8	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	80	9	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	80	10	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	80	11	dermatology	dermatology	NN
work_4ezbiswdwvaltiifn3v3mawqzu	80	12	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	80	13	insisting	insist	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	80	14	on	on	IN
work_4ezbiswdwvaltiifn3v3mawqzu	80	15	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	80	16	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	80	17	could	could	MD
work_4ezbiswdwvaltiifn3v3mawqzu	80	18	impart	impart	VB
work_4ezbiswdwvaltiifn3v3mawqzu	80	19	an	an	DT
work_4ezbiswdwvaltiifn3v3mawqzu	80	20	extensive	extensive	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	80	21	labor	labor	NN
work_4ezbiswdwvaltiifn3v3mawqzu	80	22	requirement	requirement	NN
work_4ezbiswdwvaltiifn3v3mawqzu	80	23	on	on	IN
work_4ezbiswdwvaltiifn3v3mawqzu	80	24	investigators	investigator	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	80	25	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	80	26	potentially	potentially	RB
work_4ezbiswdwvaltiifn3v3mawqzu	80	27	serve	serve	VB
work_4ezbiswdwvaltiifn3v3mawqzu	80	28	as	as	IN
work_4ezbiswdwvaltiifn3v3mawqzu	80	29	an	an	DT
work_4ezbiswdwvaltiifn3v3mawqzu	80	30	impediment	impediment	NN
work_4ezbiswdwvaltiifn3v3mawqzu	80	31	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	80	32	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	80	33	publication	publication	NN
work_4ezbiswdwvaltiifn3v3mawqzu	80	34	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	80	35	current	current	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	80	36	ongo-	ongo-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	80	37	ing	ing	NN
work_4ezbiswdwvaltiifn3v3mawqzu	80	38	studies	study	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	80	39	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	81	1	Because	because	IN
work_4ezbiswdwvaltiifn3v3mawqzu	81	2	journal	journal	NN
work_4ezbiswdwvaltiifn3v3mawqzu	81	3	submission	submission	NN
work_4ezbiswdwvaltiifn3v3mawqzu	81	4	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	81	5	peer	peer	NN
work_4ezbiswdwvaltiifn3v3mawqzu	81	6	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	81	7	edi-	edi-	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	81	8	torial	torial	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	81	9	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	81	10	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	81	11	late	late	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	81	12	steps	step	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	81	13	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	81	14	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	81	15	publication	publication	NN
work_4ezbiswdwvaltiifn3v3mawqzu	81	16	process	process	NN
work_4ezbiswdwvaltiifn3v3mawqzu	81	17	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	81	18	more	more	RBR
work_4ezbiswdwvaltiifn3v3mawqzu	81	19	efficient	efficient	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	81	20	policy	policy	NN
work_4ezbiswdwvaltiifn3v3mawqzu	81	21	might	may	MD
work_4ezbiswdwvaltiifn3v3mawqzu	81	22	involve	involve	VB
work_4ezbiswdwvaltiifn3v3mawqzu	81	23	requiring	require	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	81	24	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	81	25	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	81	26	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	81	27	approval	approval	NN
work_4ezbiswdwvaltiifn3v3mawqzu	81	28	at	at	IN
work_4ezbiswdwvaltiifn3v3mawqzu	81	29	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	81	30	institutional	institutional	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	81	31	review	review	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	81	32	board	board	NN
work_4ezbiswdwvaltiifn3v3mawqzu	81	33	level	level	NN
work_4ezbiswdwvaltiifn3v3mawqzu	81	34	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	82	1	Some	some	DT
work_4ezbiswdwvaltiifn3v3mawqzu	82	2	govern-	govern-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	82	3	ment	ment	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	82	4	bodies	body	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	82	5	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	82	6	such	such	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	82	7	as	as	IN
work_4ezbiswdwvaltiifn3v3mawqzu	82	8	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	82	9	United	United	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	82	10	Kingdom	Kingdom	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	82	11	Medical	Medical	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	82	12	Research	Research	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	82	13	Council	Council	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	82	14	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	82	15	already	already	RB
work_4ezbiswdwvaltiifn3v3mawqzu	82	16	insist	insist	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	82	17	on	on	IN
work_4ezbiswdwvaltiifn3v3mawqzu	82	18	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	82	19	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	82	20	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	82	21	or	or	CC
work_4ezbiswdwvaltiifn3v3mawqzu	82	22	reference	reference	NN
work_4ezbiswdwvaltiifn3v3mawqzu	82	23	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	82	24	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	82	25	published	publish	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	82	26	one	one	NN
work_4ezbiswdwvaltiifn3v3mawqzu	82	27	before	before	IN
work_4ezbiswdwvaltiifn3v3mawqzu	82	28	considering	consider	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	82	29	funding	fund	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	82	30	new	new	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	82	31	clinical	clinical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	82	32	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	82	33	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	83	1	This	this	DT
work_4ezbiswdwvaltiifn3v3mawqzu	83	2	requirement	requirement	NN
work_4ezbiswdwvaltiifn3v3mawqzu	83	3	puts	put	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	83	4	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	83	5	proposed	propose	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	83	6	research	research	NN
work_4ezbiswdwvaltiifn3v3mawqzu	83	7	into	into	IN
work_4ezbiswdwvaltiifn3v3mawqzu	83	8	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	83	9	context	context	NN
work_4ezbiswdwvaltiifn3v3mawqzu	83	10	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	83	11	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	83	12	existing	exist	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	83	13	body	body	NN
work_4ezbiswdwvaltiifn3v3mawqzu	83	14	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	83	15	medical	medical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	83	16	evidence	evidence	NN
work_4ezbiswdwvaltiifn3v3mawqzu	83	17	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	83	18	helps	help	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	83	19	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	83	20	avoid	avoid	VB
work_4ezbiswdwvaltiifn3v3mawqzu	83	21	duplicative	duplicative	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	83	22	study	study	NN
work_4ezbiswdwvaltiifn3v3mawqzu	83	23	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	84	1	Although	although	IN
work_4ezbiswdwvaltiifn3v3mawqzu	84	2	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	84	3	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	84	4	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	84	5	powerful	powerful	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	84	6	tools	tool	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	84	7	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	84	8	caution	caution	NN
work_4ezbiswdwvaltiifn3v3mawqzu	84	9	must	must	MD
work_4ezbiswdwvaltiifn3v3mawqzu	84	10	be	be	VB
work_4ezbiswdwvaltiifn3v3mawqzu	84	11	exercised	exercise	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	84	12	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	84	13	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	84	14	consideration	consideration	NN
work_4ezbiswdwvaltiifn3v3mawqzu	84	15	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	84	16	policy	policy	NN
work_4ezbiswdwvaltiifn3v3mawqzu	84	17	change	change	NN
work_4ezbiswdwvaltiifn3v3mawqzu	84	18	that	that	WDT
work_4ezbiswdwvaltiifn3v3mawqzu	84	19	could	could	MD
work_4ezbiswdwvaltiifn3v3mawqzu	84	20	potentially	potentially	RB
work_4ezbiswdwvaltiifn3v3mawqzu	84	21	hinder	hinder	VB
work_4ezbiswdwvaltiifn3v3mawqzu	84	22	clinically	clinically	RB
work_4ezbiswdwvaltiifn3v3mawqzu	84	23	useful	useful	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	84	24	research	research	NN
work_4ezbiswdwvaltiifn3v3mawqzu	84	25	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	85	1	Insisting	insist	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	85	2	that	that	IN
work_4ezbiswdwvaltiifn3v3mawqzu	85	3	all	all	DT
work_4ezbiswdwvaltiifn3v3mawqzu	85	4	new	new	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	85	5	studies	study	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	85	6	should	should	MD
work_4ezbiswdwvaltiifn3v3mawqzu	85	7	be	be	VB
work_4ezbiswdwvaltiifn3v3mawqzu	85	8	preceded	precede	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	85	9	by	by	IN
work_4ezbiswdwvaltiifn3v3mawqzu	85	10	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	85	11	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	85	12	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	85	13	may	may	MD
work_4ezbiswdwvaltiifn3v3mawqzu	85	14	be	be	VB
work_4ezbiswdwvaltiifn3v3mawqzu	85	15	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	85	16	bit	bit	NN
work_4ezbiswdwvaltiifn3v3mawqzu	85	17	drastic	drastic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	85	18	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	85	19	dermatology	dermatology	NN
work_4ezbiswdwvaltiifn3v3mawqzu	85	20	at	at	IN
work_4ezbiswdwvaltiifn3v3mawqzu	85	21	this	this	DT
work_4ezbiswdwvaltiifn3v3mawqzu	85	22	time	time	NN
work_4ezbiswdwvaltiifn3v3mawqzu	85	23	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	86	1	Insisting	insist	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	86	2	on	on	IN
work_4ezbiswdwvaltiifn3v3mawqzu	86	3	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	86	4	need	need	NN
work_4ezbiswdwvaltiifn3v3mawqzu	86	5	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	86	6	mention	mention	VB
work_4ezbiswdwvaltiifn3v3mawqzu	86	7	whether	whether	IN
work_4ezbiswdwvaltiifn3v3mawqzu	86	8	or	or	CC
work_4ezbiswdwvaltiifn3v3mawqzu	86	9	not	not	RB
work_4ezbiswdwvaltiifn3v3mawqzu	86	10	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	86	11	system-	system-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	86	12	atic	atic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	86	13	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	86	14	has	have	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	86	15	been	be	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	86	16	done	do	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	86	17	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	86	18	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	86	19	how	how	WRB
work_4ezbiswdwvaltiifn3v3mawqzu	86	20	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	86	21	existing	exist	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	86	22	body	body	NN
work_4ezbiswdwvaltiifn3v3mawqzu	86	23	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	86	24	evi-	evi-	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	86	25	dence	dence	NN
work_4ezbiswdwvaltiifn3v3mawqzu	86	26	dictated	dictate	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	86	27	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	86	28	need	need	NN
work_4ezbiswdwvaltiifn3v3mawqzu	86	29	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	86	30	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	86	31	new	new	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	86	32	study	study	NN
work_4ezbiswdwvaltiifn3v3mawqzu	86	33	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	86	34	does	do	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	86	35	seem	seem	VB
work_4ezbiswdwvaltiifn3v3mawqzu	86	36	entirely	entirely	RB
work_4ezbiswdwvaltiifn3v3mawqzu	86	37	reasonable	reasonable	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	86	38	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	86	39	achievable	achievable	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	86	40	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	86	41	however	however	RB
work_4ezbiswdwvaltiifn3v3mawqzu	86	42	—	—	:
work_4ezbiswdwvaltiifn3v3mawqzu	86	43	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	86	44	move	move	NN
work_4ezbiswdwvaltiifn3v3mawqzu	86	45	that	that	WDT
work_4ezbiswdwvaltiifn3v3mawqzu	86	46	could	could	MD
work_4ezbiswdwvaltiifn3v3mawqzu	86	47	discourage	discourage	VB
work_4ezbiswdwvaltiifn3v3mawqzu	86	48	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	86	49	nth	nth	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	86	50	placebo	placebo	NN
work_4ezbiswdwvaltiifn3v3mawqzu	86	51	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	86	52	controlled	control	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	86	53	trial	trial	NN
work_4ezbiswdwvaltiifn3v3mawqzu	86	54	on	on	IN
work_4ezbiswdwvaltiifn3v3mawqzu	86	55	another	another	DT
work_4ezbiswdwvaltiifn3v3mawqzu	86	56	“	"	``
work_4ezbiswdwvaltiifn3v3mawqzu	86	57	me-	me-	NN
work_4ezbiswdwvaltiifn3v3mawqzu	86	58	too	too	RB
work_4ezbiswdwvaltiifn3v3mawqzu	86	59	”	"	''
work_4ezbiswdwvaltiifn3v3mawqzu	86	60	product	product	NN
work_4ezbiswdwvaltiifn3v3mawqzu	86	61	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	87	1	Current	current	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	87	2	publication	publication	NN
work_4ezbiswdwvaltiifn3v3mawqzu	87	3	methodology	methodology	NN
work_4ezbiswdwvaltiifn3v3mawqzu	87	4	may	may	MD
work_4ezbiswdwvaltiifn3v3mawqzu	87	5	lead	lead	VB
work_4ezbiswdwvaltiifn3v3mawqzu	87	6	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	87	7	selective	selective	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	87	8	publication	publication	NN
work_4ezbiswdwvaltiifn3v3mawqzu	87	9	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	87	10	results	result	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	87	11	that	that	WDT
work_4ezbiswdwvaltiifn3v3mawqzu	87	12	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	87	13	more	more	RBR
work_4ezbiswdwvaltiifn3v3mawqzu	87	14	favorable	favorable	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	87	15	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	87	16	study	study	VB
work_4ezbiswdwvaltiifn3v3mawqzu	87	17	spon-	spon-	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	87	18	sors	sor	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	87	19	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	87	20	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	87	21	publication	publication	NN
work_4ezbiswdwvaltiifn3v3mawqzu	87	22	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	87	23	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	87	24	that	that	WDT
work_4ezbiswdwvaltiifn3v3mawqzu	87	25	deviate	deviate	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	87	26	from	from	IN
work_4ezbiswdwvaltiifn3v3mawqzu	87	27	original	original	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	87	28	study	study	NN
work_4ezbiswdwvaltiifn3v3mawqzu	87	29	protocols	protocol	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	87	30	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	87	31	Al	Al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	87	32	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	87	33	Marzouki	Marzouki	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	87	34	et	et	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	87	35	al	al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	87	36	.	.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	87	37	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	87	38	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	87	39	;	;	:
work_4ezbiswdwvaltiifn3v3mawqzu	87	40	Smith	Smith	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	87	41	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	87	42	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	87	43	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	87	44	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	88	1	A	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	88	2	newly	newly	RB
work_4ezbiswdwvaltiifn3v3mawqzu	88	3	proposed	propose	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	88	4	system	system	NN
work_4ezbiswdwvaltiifn3v3mawqzu	88	5	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	88	6	reporting	report	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	88	7	clinical	clinical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	88	8	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	88	9	would	would	MD
work_4ezbiswdwvaltiifn3v3mawqzu	88	10	require	require	VB
work_4ezbiswdwvaltiifn3v3mawqzu	88	11	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	88	12	posting	posting	NN
work_4ezbiswdwvaltiifn3v3mawqzu	88	13	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	88	14	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	88	15	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	88	16	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	88	17	on	on	IN
work_4ezbiswdwvaltiifn3v3mawqzu	88	18	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	88	19	Internet	internet	NN
work_4ezbiswdwvaltiifn3v3mawqzu	88	20	as	as	RB
work_4ezbiswdwvaltiifn3v3mawqzu	88	21	well	well	RB
work_4ezbiswdwvaltiifn3v3mawqzu	88	22	as	as	IN
work_4ezbiswdwvaltiifn3v3mawqzu	88	23	any	any	DT
work_4ezbiswdwvaltiifn3v3mawqzu	88	24	subsequent	subsequent	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	88	25	study	study	NN
work_4ezbiswdwvaltiifn3v3mawqzu	88	26	protocols	protocol	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	88	27	related	relate	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	88	28	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	88	29	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	88	30	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	88	31	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	88	32	Smith	Smith	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	88	33	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	88	34	Roberts	Roberts	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	88	35	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	88	36	2006	2006	CD
work_4ezbiswdwvaltiifn3v3mawqzu	88	37	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	88	38	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	89	1	This	this	DT
work_4ezbiswdwvaltiifn3v3mawqzu	89	2	system	system	NN
work_4ezbiswdwvaltiifn3v3mawqzu	89	3	would	would	MD
work_4ezbiswdwvaltiifn3v3mawqzu	89	4	be	be	VB
work_4ezbiswdwvaltiifn3v3mawqzu	89	5	freely	freely	RB
work_4ezbiswdwvaltiifn3v3mawqzu	89	6	accessible	accessible	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	89	7	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	89	8	patients	patient	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	89	9	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	89	10	researchers	researcher	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	89	11	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	89	12	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	89	13	editors	editor	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	89	14	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	89	15	would	would	MD
work_4ezbiswdwvaltiifn3v3mawqzu	89	16	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	89	17	1	1	LS
work_4ezbiswdwvaltiifn3v3mawqzu	89	18	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	89	19	force	force	NN
work_4ezbiswdwvaltiifn3v3mawqzu	89	20	investigators	investigator	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	89	21	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	89	22	follow	follow	VB
work_4ezbiswdwvaltiifn3v3mawqzu	89	23	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	89	24	original	original	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	89	25	trial	trial	NN
work_4ezbiswdwvaltiifn3v3mawqzu	89	26	design	design	NN
work_4ezbiswdwvaltiifn3v3mawqzu	89	27	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	89	28	thereby	thereby	RB
work_4ezbiswdwvaltiifn3v3mawqzu	89	29	preventing	prevent	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	89	30	selective	selective	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	89	31	publication	publication	NN
work_4ezbiswdwvaltiifn3v3mawqzu	89	32	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	89	33	results	result	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	89	34	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	89	35	misleading	misleading	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	89	36	post	post	FW
work_4ezbiswdwvaltiifn3v3mawqzu	89	37	hoc	hoc	FW
work_4ezbiswdwvaltiifn3v3mawqzu	89	38	analyses	analysis	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	89	39	;	;	:
work_4ezbiswdwvaltiifn3v3mawqzu	89	40	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	89	41	2	2	LS
work_4ezbiswdwvaltiifn3v3mawqzu	89	42	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	89	43	allow	allow	VB
work_4ezbiswdwvaltiifn3v3mawqzu	89	44	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	89	45	feedback	feedback	NN
work_4ezbiswdwvaltiifn3v3mawqzu	89	46	at	at	IN
work_4ezbiswdwvaltiifn3v3mawqzu	89	47	any	any	DT
work_4ezbiswdwvaltiifn3v3mawqzu	89	48	stage	stage	NN
work_4ezbiswdwvaltiifn3v3mawqzu	89	49	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	89	50	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	89	51	trial	trial	NN
work_4ezbiswdwvaltiifn3v3mawqzu	89	52	;	;	:
work_4ezbiswdwvaltiifn3v3mawqzu	89	53	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	89	54	3	3	LS
work_4ezbiswdwvaltiifn3v3mawqzu	89	55	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	89	56	allow	allow	VB
work_4ezbiswdwvaltiifn3v3mawqzu	89	57	research	research	NN
work_4ezbiswdwvaltiifn3v3mawqzu	89	58	teams	team	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	89	59	contemplat-	contemplat-	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	89	60	ing	ing	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	89	61	undertaking	undertake	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	89	62	new	new	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	89	63	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	89	64	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	89	65	see	see	VB
work_4ezbiswdwvaltiifn3v3mawqzu	89	66	whether	whether	IN
work_4ezbiswdwvaltiifn3v3mawqzu	89	67	their	-PRON-	PRP$
work_4ezbiswdwvaltiifn3v3mawqzu	89	68	proposed	propose	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	89	69	work	work	NN
work_4ezbiswdwvaltiifn3v3mawqzu	89	70	has	have	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	89	71	already	already	RB
work_4ezbiswdwvaltiifn3v3mawqzu	89	72	been	be	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	89	73	done	do	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	89	74	;	;	:
work_4ezbiswdwvaltiifn3v3mawqzu	89	75	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	89	76	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	89	77	4	4	LS
work_4ezbiswdwvaltiifn3v3mawqzu	89	78	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	89	79	permit	permit	VB
work_4ezbiswdwvaltiifn3v3mawqzu	89	80	those	those	DT
work_4ezbiswdwvaltiifn3v3mawqzu	89	81	report-	report-	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	89	82	ing	ing	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	89	83	completed	complete	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	89	84	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	89	85	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	89	86	refer	refer	VB
work_4ezbiswdwvaltiifn3v3mawqzu	89	87	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	89	88	key	key	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	89	89	ongoing	ongoing	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	89	90	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	89	91	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	90	1	Similarly	similarly	RB
work_4ezbiswdwvaltiifn3v3mawqzu	90	2	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	90	3	more	more	JJR
work_4ezbiswdwvaltiifn3v3mawqzu	90	4	efforts	effort	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	90	5	need	need	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	90	6	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	90	7	be	be	VB
work_4ezbiswdwvaltiifn3v3mawqzu	90	8	directed	direct	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	90	9	at	at	IN
work_4ezbiswdwvaltiifn3v3mawqzu	90	10	registering	register	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	90	11	all	all	DT
work_4ezbiswdwvaltiifn3v3mawqzu	90	12	clinical	clinical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	90	13	tri-	tri-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	90	14	als	als	NN
work_4ezbiswdwvaltiifn3v3mawqzu	90	15	prospectively	prospectively	RB
work_4ezbiswdwvaltiifn3v3mawqzu	90	16	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	90	17	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	90	18	publicly	publicly	RB
work_4ezbiswdwvaltiifn3v3mawqzu	90	19	searchable	searchable	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	90	20	database	database	NN
work_4ezbiswdwvaltiifn3v3mawqzu	90	21	such	such	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	90	22	as	as	IN
work_4ezbiswdwvaltiifn3v3mawqzu	90	23	Current	Current	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	90	24	Controlled	Controlled	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	90	25	Trials	Trials	NNPS
work_4ezbiswdwvaltiifn3v3mawqzu	90	26	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	90	27	http://www.controlled-trials.com	http://www.controlled-trials.com	ADD
work_4ezbiswdwvaltiifn3v3mawqzu	90	28	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	90	29	or	or	CC
work_4ezbiswdwvaltiifn3v3mawqzu	90	30	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	90	31	Cochrane	Cochrane	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	90	32	Skin	Skin	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	90	33	Group	Group	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	90	34	’s	’s	POS
work_4ezbiswdwvaltiifn3v3mawqzu	90	35	trial	trial	NN
work_4ezbiswdwvaltiifn3v3mawqzu	90	36	register	register	NN
work_4ezbiswdwvaltiifn3v3mawqzu	90	37	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	90	38	http://www	http://www	ADD
work_4ezbiswdwvaltiifn3v3mawqzu	90	39	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	91	1	nottingham.ac.uk/ongoingskintrials/	nottingham.ac.uk/ongoingskintrials/	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	91	2	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	91	3	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	91	4	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	91	5	free	free	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	91	6	resource	resource	NN
work_4ezbiswdwvaltiifn3v3mawqzu	91	7	that	that	WDT
work_4ezbiswdwvaltiifn3v3mawqzu	91	8	has	have	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	91	9	recently	recently	RB
work_4ezbiswdwvaltiifn3v3mawqzu	91	10	been	be	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	91	11	updated	update	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	91	12	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	91	13	incorporate	incorporate	VB
work_4ezbiswdwvaltiifn3v3mawqzu	91	14	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	91	15	World	World	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	91	16	Health	Health	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	91	17	Organization	Organization	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	91	18	’s	’s	POS
work_4ezbiswdwvaltiifn3v3mawqzu	91	19	latest	late	JJS
work_4ezbiswdwvaltiifn3v3mawqzu	91	20	recommendations	recommendation	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	91	21	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	91	22	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	91	23	registra-	registra-	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	91	24	tion	tion	NN
work_4ezbiswdwvaltiifn3v3mawqzu	91	25	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	92	1	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	92	2	Journal	Journal	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	92	3	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	92	4	Investigative	Investigative	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	92	5	Dermatology	Dermatology	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	92	6	requires	require	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	92	7	reg-	reg-	RB
work_4ezbiswdwvaltiifn3v3mawqzu	92	8	istration	istration	NN
work_4ezbiswdwvaltiifn3v3mawqzu	92	9	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	92	10	all	all	DT
work_4ezbiswdwvaltiifn3v3mawqzu	92	11	clinical	clinical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	92	12	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	92	13	that	that	WDT
work_4ezbiswdwvaltiifn3v3mawqzu	92	14	started	start	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	92	15	enrollment	enrollment	NN
work_4ezbiswdwvaltiifn3v3mawqzu	92	16	after	after	IN
work_4ezbiswdwvaltiifn3v3mawqzu	92	17	July	July	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	92	18	1	1	CD
work_4ezbiswdwvaltiifn3v3mawqzu	92	19	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	92	20	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	92	21	prior	prior	RB
work_4ezbiswdwvaltiifn3v3mawqzu	92	22	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	92	23	publication	publication	NN
work_4ezbiswdwvaltiifn3v3mawqzu	92	24	consideration	consideration	NN
work_4ezbiswdwvaltiifn3v3mawqzu	92	25	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	92	26	Williams	Williams	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	92	27	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	92	28	Stern	Stern	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	92	29	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	92	30	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	92	31	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	92	32	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	93	1	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	93	2	Journal	Journal	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	93	3	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	93	4	Investigative	Investigative	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	93	5	Dermatology	Dermatology	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	93	6	fol-	fol-	NN
work_4ezbiswdwvaltiifn3v3mawqzu	93	7	lows	low	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	93	8	International	International	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	93	9	Committee	Committee	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	93	10	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	93	11	Medical	Medical	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	93	12	Journal	Journal	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	93	13	Editors	Editors	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	93	14	standards	standard	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	93	15	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	93	16	information	information	NN
work_4ezbiswdwvaltiifn3v3mawqzu	93	17	regarding	regard	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	93	18	this	this	DT
work_4ezbiswdwvaltiifn3v3mawqzu	93	19	policy	policy	NN
work_4ezbiswdwvaltiifn3v3mawqzu	93	20	can	can	MD
work_4ezbiswdwvaltiifn3v3mawqzu	93	21	be	be	VB
work_4ezbiswdwvaltiifn3v3mawqzu	93	22	found	find	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	93	23	at	at	IN
work_4ezbiswdwvaltiifn3v3mawqzu	93	24	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	93	25	journal	journal	NN
work_4ezbiswdwvaltiifn3v3mawqzu	93	26	's	's	POS
work_4ezbiswdwvaltiifn3v3mawqzu	93	27	website	website	NN
work_4ezbiswdwvaltiifn3v3mawqzu	93	28	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	93	29	http://www.nature.com/jid/	http://www.nature.com/jid/	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	93	30	author_instructions.html#clinical-trials-registration	author_instructions.html#clinical-trials-registration	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	93	31	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	93	32	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	94	1	Redundant	redundant	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	94	2	studies	study	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	94	3	waste	waste	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	94	4	valuable	valuable	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	94	5	resources	resource	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	94	6	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	94	7	including	include	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	94	8	those	those	DT
work_4ezbiswdwvaltiifn3v3mawqzu	94	9	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	94	10	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	94	11	funding	funding	NN
work_4ezbiswdwvaltiifn3v3mawqzu	94	12	body	body	NN
work_4ezbiswdwvaltiifn3v3mawqzu	94	13	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	94	14	researchers	researcher	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	94	15	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	94	16	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	94	17	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	94	18	most	most	RBS
work_4ezbiswdwvaltiifn3v3mawqzu	94	19	importantly	importantly	RB
work_4ezbiswdwvaltiifn3v3mawqzu	94	20	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	94	21	2360	2360	CD
work_4ezbiswdwvaltiifn3v3mawqzu	94	22	Journal	Journal	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	94	23	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	94	24	Investigative	Investigative	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	94	25	Dermatology	Dermatology	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	94	26	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	94	27	2006	2006	CD
work_4ezbiswdwvaltiifn3v3mawqzu	94	28	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	94	29	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	94	30	Volume	volume	NN
work_4ezbiswdwvaltiifn3v3mawqzu	94	31	126	126	CD
work_4ezbiswdwvaltiifn3v3mawqzu	94	32	©	©	CD
work_4ezbiswdwvaltiifn3v3mawqzu	94	33	2006	2006	CD
work_4ezbiswdwvaltiifn3v3mawqzu	94	34	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	94	35	Society	Society	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	94	36	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	94	37	Investigative	Investigative	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	94	38	Dermatology	Dermatology	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	94	39	patients	patient	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	94	40	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	94	41	who	who	WP
work_4ezbiswdwvaltiifn3v3mawqzu	94	42	usually	usually	RB
work_4ezbiswdwvaltiifn3v3mawqzu	94	43	participate	participate	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	94	44	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	94	45	clinical	clinical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	94	46	studies	study	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	94	47	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	94	48	altru-	altru-	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	94	49	istic	istic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	94	50	reasons	reason	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	94	51	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	95	1	A	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	95	2	policy	policy	NN
work_4ezbiswdwvaltiifn3v3mawqzu	95	3	at	at	IN
work_4ezbiswdwvaltiifn3v3mawqzu	95	4	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	95	5	journal	journal	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	95	6	or	or	CC
work_4ezbiswdwvaltiifn3v3mawqzu	95	7	institutional	institutional	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	95	8	review	review	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	95	9	board	board	NN
work_4ezbiswdwvaltiifn3v3mawqzu	95	10	level	level	NN
work_4ezbiswdwvaltiifn3v3mawqzu	95	11	requiring	require	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	95	12	any	any	DT
work_4ezbiswdwvaltiifn3v3mawqzu	95	13	new	new	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	95	14	study	study	NN
work_4ezbiswdwvaltiifn3v3mawqzu	95	15	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	95	16	relate	relate	VB
work_4ezbiswdwvaltiifn3v3mawqzu	95	17	its	-PRON-	PRP$
work_4ezbiswdwvaltiifn3v3mawqzu	95	18	findings	finding	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	95	19	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	95	20	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	95	21	body	body	NN
work_4ezbiswdwvaltiifn3v3mawqzu	95	22	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	95	23	existing	exist	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	95	24	evidence	evidence	NN
work_4ezbiswdwvaltiifn3v3mawqzu	95	25	should	should	MD
work_4ezbiswdwvaltiifn3v3mawqzu	95	26	help	help	VB
work_4ezbiswdwvaltiifn3v3mawqzu	95	27	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	95	28	define	define	VB
work_4ezbiswdwvaltiifn3v3mawqzu	95	29	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	95	30	need	need	NN
work_4ezbiswdwvaltiifn3v3mawqzu	95	31	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	95	32	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	95	33	study	study	NN
work_4ezbiswdwvaltiifn3v3mawqzu	95	34	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	95	35	sharpen	sharpen	VB
work_4ezbiswdwvaltiifn3v3mawqzu	95	36	its	-PRON-	PRP$
work_4ezbiswdwvaltiifn3v3mawqzu	95	37	methodology	methodology	NN
work_4ezbiswdwvaltiifn3v3mawqzu	95	38	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	96	1	This	this	DT
work_4ezbiswdwvaltiifn3v3mawqzu	96	2	requirement	requirement	NN
work_4ezbiswdwvaltiifn3v3mawqzu	96	3	would	would	MD
work_4ezbiswdwvaltiifn3v3mawqzu	96	4	help	help	VB
work_4ezbiswdwvaltiifn3v3mawqzu	96	5	dissuade	dissuade	VB
work_4ezbiswdwvaltiifn3v3mawqzu	96	6	investigators	investigator	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	96	7	from	from	IN
work_4ezbiswdwvaltiifn3v3mawqzu	96	8	performing	perform	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	96	9	duplica-	duplica-	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	96	10	tive	tive	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	96	11	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	96	12	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	96	13	better	well	RBR
work_4ezbiswdwvaltiifn3v3mawqzu	96	14	ensure	ensure	VB
work_4ezbiswdwvaltiifn3v3mawqzu	96	15	that	that	IN
work_4ezbiswdwvaltiifn3v3mawqzu	96	16	scarce	scarce	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	96	17	resources	resource	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	96	18	available	available	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	96	19	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	96	20	clinical	clinical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	96	21	dermatology	dermatology	NN
work_4ezbiswdwvaltiifn3v3mawqzu	96	22	research	research	NN
work_4ezbiswdwvaltiifn3v3mawqzu	96	23	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	96	24	targeted	target	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	96	25	toward	toward	IN
work_4ezbiswdwvaltiifn3v3mawqzu	96	26	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	96	27	most	most	RBS
work_4ezbiswdwvaltiifn3v3mawqzu	96	28	urgent	urgent	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	96	29	research	research	NN
work_4ezbiswdwvaltiifn3v3mawqzu	96	30	gaps	gap	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	96	31	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	97	1	CONFLICT	conflict	NN
work_4ezbiswdwvaltiifn3v3mawqzu	97	2	OF	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	97	3	INTEREST	interest	NN
work_4ezbiswdwvaltiifn3v3mawqzu	97	4	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	97	5	authors	author	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	97	6	state	state	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	97	7	no	no	DT
work_4ezbiswdwvaltiifn3v3mawqzu	97	8	conflict	conflict	NN
work_4ezbiswdwvaltiifn3v3mawqzu	97	9	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	97	10	interest	interest	NN
work_4ezbiswdwvaltiifn3v3mawqzu	97	11	but	but	CC
work_4ezbiswdwvaltiifn3v3mawqzu	97	12	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	97	13	all	all	DT
work_4ezbiswdwvaltiifn3v3mawqzu	97	14	enthusiastic	enthusiastic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	97	15	participants	participant	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	97	16	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	97	17	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	97	18	Cochrane	Cochrane	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	97	19	Collaboration	Collaboration	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	97	20	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	98	1	ACKNOWLEDGMENTS	acknowledgment	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	98	2	This	this	DT
work_4ezbiswdwvaltiifn3v3mawqzu	98	3	work	work	NN
work_4ezbiswdwvaltiifn3v3mawqzu	98	4	was	be	VBD
work_4ezbiswdwvaltiifn3v3mawqzu	98	5	supported	support	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	98	6	by	by	IN
work_4ezbiswdwvaltiifn3v3mawqzu	98	7	grant	grant	NN
work_4ezbiswdwvaltiifn3v3mawqzu	98	8	T32	T32	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	98	9	ARO7411	ARO7411	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	98	10	from	from	IN
work_4ezbiswdwvaltiifn3v3mawqzu	98	11	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	98	12	US	US	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	98	13	National	National	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	98	14	Institutes	Institutes	NNPS
work_4ezbiswdwvaltiifn3v3mawqzu	98	15	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	98	16	Health	Health	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	98	17	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	98	18	Bethesda	Bethesda	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	98	19	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	98	20	Maryland	Maryland	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	98	21	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	98	22	USA	USA	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	98	23	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	98	24	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	98	25	S.R.F.	S.R.F.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	99	1	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	99	2	;	;	:
work_4ezbiswdwvaltiifn3v3mawqzu	99	3	grant	grant	VB
work_4ezbiswdwvaltiifn3v3mawqzu	99	4	K07	K07	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	99	5	CA92550	ca92550	NN
work_4ezbiswdwvaltiifn3v3mawqzu	99	6	from	from	IN
work_4ezbiswdwvaltiifn3v3mawqzu	99	7	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	99	8	National	National	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	99	9	Cancer	Cancer	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	99	10	Institute	Institute	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	99	11	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	99	12	Bethesda	Bethesda	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	99	13	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	99	14	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	99	15	R.P.D.	R.P.D.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	100	1	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	100	2	;	;	:
work_4ezbiswdwvaltiifn3v3mawqzu	100	3	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	100	4	University	University	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	100	5	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	100	6	Colorado	Colorado	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	100	7	Cancer	Cancer	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	100	8	Center	Center	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	100	9	;	;	:
work_4ezbiswdwvaltiifn3v3mawqzu	100	10	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	100	11	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	100	12	United	United	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	100	13	Kingdom	Kingdom	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	100	14	National	National	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	100	15	Health	Health	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	100	16	Service	Service	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	100	17	Research	Research	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	100	18	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	100	19	Development	Development	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	100	20	Programme	Programme	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	100	21	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	100	22	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	100	23	H.C.W.	H.C.W.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	100	24	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	100	25	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	101	1	Scott	Scott	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	2	R.	R.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	3	Freeman1	Freeman1	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	4	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	5	Hywel	Hywel	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	6	C.	C.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	7	Williams2	Williams2	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	8	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	101	9	Robert	Robert	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	10	P.	P.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	11	Dellavalle1,3	dellavalle1,3	CD
work_4ezbiswdwvaltiifn3v3mawqzu	101	12	1University	1University	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	13	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	101	14	Colorado	Colorado	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	15	at	at	IN
work_4ezbiswdwvaltiifn3v3mawqzu	101	16	Denver	Denver	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	17	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	101	18	Health	Health	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	19	Sciences	Sciences	NNPS
work_4ezbiswdwvaltiifn3v3mawqzu	101	20	Center	Center	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	21	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	22	Department	Department	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	23	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	101	24	Dermatology	Dermatology	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	25	Research	Research	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	26	Laboratories	Laboratories	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	27	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	28	Aurora	Aurora	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	29	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	30	Colorado	Colorado	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	31	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	32	USA	USA	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	33	;	;	:
work_4ezbiswdwvaltiifn3v3mawqzu	101	34	2Centre	2centre	CD
work_4ezbiswdwvaltiifn3v3mawqzu	101	35	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	101	36	Evidence	Evidence	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	37	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	101	38	Based	Based	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	39	Dermatology	Dermatology	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	40	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	41	Nottingham	Nottingham	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	42	University	University	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	43	Hospital	Hospital	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	44	National	National	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	45	Health	Health	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	46	Service	Service	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	47	Trust	Trust	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	48	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	49	University	University	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	50	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	101	51	Nottingham	Nottingham	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	52	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	53	Nottingham	Nottingham	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	54	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	55	United	United	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	56	Kingdom	Kingdom	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	57	;	;	:
work_4ezbiswdwvaltiifn3v3mawqzu	101	58	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	101	59	3Department	3Department	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	60	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	101	61	Veterans	Veterans	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	62	Affairs	Affairs	NNPS
work_4ezbiswdwvaltiifn3v3mawqzu	101	63	Medical	Medical	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	64	Center	Center	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	65	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	66	Dermatology	Dermatology	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	67	Service	Service	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	68	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	69	Denver	Denver	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	70	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	71	Colorado	Colorado	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	72	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	73	USA	USA	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	74	Correspondence	Correspondence	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	75	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	101	76	Dr.	Dr.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	77	Robert	Robert	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	78	P.	P.	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	79	Dellavalle	Dellavalle	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	80	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	81	Department	Department	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	82	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	101	83	Veterans	Veterans	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	84	Affairs	Affairs	NNPS
work_4ezbiswdwvaltiifn3v3mawqzu	101	85	Medical	Medical	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	86	Center	Center	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	87	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	88	Dermatology	Dermatology	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	89	Service	Service	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	90	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	91	1055	1055	CD
work_4ezbiswdwvaltiifn3v3mawqzu	101	92	Clermont	Clermont	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	93	Street	Street	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	94	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	95	#	#	$
work_4ezbiswdwvaltiifn3v3mawqzu	101	96	165	165	CD
work_4ezbiswdwvaltiifn3v3mawqzu	101	97	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	98	Denver	Denver	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	99	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	100	Colorado	Colorado	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	101	80220	80220	CD
work_4ezbiswdwvaltiifn3v3mawqzu	101	102	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	101	103	USA	USA	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	101	104	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	102	1	E	e	NN
work_4ezbiswdwvaltiifn3v3mawqzu	102	2	-	-	NN
work_4ezbiswdwvaltiifn3v3mawqzu	102	3	mail	mail	NN
work_4ezbiswdwvaltiifn3v3mawqzu	102	4	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	102	5	robert.dellavalle@uchsc.edu	robert.dellavalle@uchsc.edu	ADD
work_4ezbiswdwvaltiifn3v3mawqzu	102	6	REFERENCES	REFERENCES	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	102	7	Al	Al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	102	8	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	102	9	Marzouki	Marzouki	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	102	10	S	S	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	102	11	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	102	12	Roberts	Roberts	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	102	13	I	I	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	102	14	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	102	15	Marshall	Marshall	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	102	16	T	T	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	102	17	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	102	18	Evans	Evans	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	102	19	S	S	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	102	20	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	102	21	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	102	22	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	102	23	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	102	24	effect	effect	NN
work_4ezbiswdwvaltiifn3v3mawqzu	102	25	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	102	26	scientific	scientific	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	102	27	misconduct	misconduct	NN
work_4ezbiswdwvaltiifn3v3mawqzu	102	28	on	on	IN
work_4ezbiswdwvaltiifn3v3mawqzu	102	29	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	102	30	results	result	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	102	31	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	102	32	clinical	clinical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	102	33	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	102	34	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	102	35	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	102	36	Delphi	Delphi	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	102	37	survey	survey	NN
work_4ezbiswdwvaltiifn3v3mawqzu	102	38	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	103	1	Contemp	Contemp	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	103	2	Clin	Clin	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	103	3	Trials	Trials	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	103	4	26:331–7	26:331–7	,
work_4ezbiswdwvaltiifn3v3mawqzu	103	5	Ashcroft	Ashcroft	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	103	6	DM	dm	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	103	7	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	103	8	Dimmock	Dimmock	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	103	9	P	p	NN
work_4ezbiswdwvaltiifn3v3mawqzu	103	10	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	103	11	Garside	Garside	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	103	12	R	R	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	103	13	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	103	14	Stein	Stein	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	103	15	K	K	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	103	16	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	103	17	Williams	Williams	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	103	18	HC	HC	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	103	19	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	103	20	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	103	21	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	103	22	Efficacy	efficacy	NN
work_4ezbiswdwvaltiifn3v3mawqzu	103	23	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	103	24	tolerability	tolerability	NN
work_4ezbiswdwvaltiifn3v3mawqzu	103	25	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	103	26	topical	topical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	103	27	pimecrolimus	pimecrolimus	NN
work_4ezbiswdwvaltiifn3v3mawqzu	103	28	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	103	29	tacrolimus	tacrolimus	NN
work_4ezbiswdwvaltiifn3v3mawqzu	103	30	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	103	31	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	103	32	treatment	treatment	NN
work_4ezbiswdwvaltiifn3v3mawqzu	103	33	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	103	34	atopic	atopic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	103	35	dermatitis	dermatitis	NN
work_4ezbiswdwvaltiifn3v3mawqzu	103	36	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	103	37	meta	meta	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	103	38	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	103	39	analysis	analysis	NN
work_4ezbiswdwvaltiifn3v3mawqzu	103	40	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	103	41	randomised	randomise	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	103	42	controlled	controlled	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	103	43	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	103	44	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	104	1	BMJ	BMJ	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	104	2	330:516	330:516	CD
work_4ezbiswdwvaltiifn3v3mawqzu	104	3	Atkins	Atkins	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	104	4	D	d	NN
work_4ezbiswdwvaltiifn3v3mawqzu	104	5	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	104	6	Fink	Fink	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	104	7	K	K	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	104	8	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	104	9	Slutsky	Slutsky	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	104	10	J	J	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	104	11	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	104	12	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	104	13	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	104	14	Better	well	JJR
work_4ezbiswdwvaltiifn3v3mawqzu	104	15	information	information	NN
work_4ezbiswdwvaltiifn3v3mawqzu	104	16	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	104	17	better	well	JJR
work_4ezbiswdwvaltiifn3v3mawqzu	104	18	health	health	NN
work_4ezbiswdwvaltiifn3v3mawqzu	104	19	care	care	NN
work_4ezbiswdwvaltiifn3v3mawqzu	104	20	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	104	21	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	104	22	Evidence	evidence	NN
work_4ezbiswdwvaltiifn3v3mawqzu	104	23	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	104	24	based	base	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	104	25	Practice	Practice	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	104	26	Center	Center	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	104	27	program	program	NN
work_4ezbiswdwvaltiifn3v3mawqzu	104	28	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	104	29	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	104	30	Agency	Agency	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	104	31	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	104	32	Healthcare	Healthcare	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	104	33	Research	Research	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	104	34	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	104	35	Quality	Quality	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	104	36	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	105	1	Ann	Ann	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	105	2	Intern	Intern	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	105	3	Med	Med	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	105	4	142:1035–41	142:1035–41	CD
work_4ezbiswdwvaltiifn3v3mawqzu	105	5	Bigby	Bigby	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	105	6	M	M	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	105	7	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	105	8	Williams	Williams	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	105	9	H	H	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	105	10	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	105	11	2003	2003	CD
work_4ezbiswdwvaltiifn3v3mawqzu	105	12	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	105	13	How	how	WRB
work_4ezbiswdwvaltiifn3v3mawqzu	105	14	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	105	15	critically	critically	RB
work_4ezbiswdwvaltiifn3v3mawqzu	105	16	appraise	appraise	VB
work_4ezbiswdwvaltiifn3v3mawqzu	105	17	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	105	18	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	105	19	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	105	20	meta	meta	NN
work_4ezbiswdwvaltiifn3v3mawqzu	105	21	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	105	22	analyses	analysis	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	105	23	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	106	1	In	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	106	2	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	106	3	Evidence	evidence	NN
work_4ezbiswdwvaltiifn3v3mawqzu	106	4	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	106	5	Based	base	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	106	6	Dermatology	Dermatology	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	106	7	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	107	1	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	107	2	Bigby	Bigby	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	3	M	M	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	4	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	107	5	Williams	Williams	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	6	H	H	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	7	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	107	8	Diepgen	Diepgen	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	9	T	T	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	10	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	107	11	Herxheimer	Herxheimer	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	12	A	A	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	13	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	107	14	Naldi	Naldi	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	15	L	L	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	16	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	107	17	Rzany	Rzany	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	18	B	B	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	19	eds	eds	NN
work_4ezbiswdwvaltiifn3v3mawqzu	107	20	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	107	21	BMJ	BMJ	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	22	Publishing	Publishing	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	23	Group	Group	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	24	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	107	25	London	London	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	26	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	107	27	pp	pp	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	28	49–55	49–55	CD
work_4ezbiswdwvaltiifn3v3mawqzu	107	29	Collier	Collier	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	30	A	A	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	31	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	107	32	Johnson	Johnson	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	33	K	K	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	34	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	107	35	Heilig	Heilig	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	36	L	L	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	37	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	107	38	Leonard	Leonard	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	39	T	T	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	40	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	107	41	Williams	Williams	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	42	H	H	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	43	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	107	44	Dellavalle	Dellavalle	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	45	RP	RP	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	46	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	107	47	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	107	48	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	107	49	A	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	107	50	win	win	NN
work_4ezbiswdwvaltiifn3v3mawqzu	107	51	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	107	52	win	win	NN
work_4ezbiswdwvaltiifn3v3mawqzu	107	53	proposition	proposition	NN
work_4ezbiswdwvaltiifn3v3mawqzu	107	54	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	107	55	fostering	foster	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	107	56	consumer	consumer	NN
work_4ezbiswdwvaltiifn3v3mawqzu	107	57	involvement	involvement	NN
work_4ezbiswdwvaltiifn3v3mawqzu	107	58	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	107	59	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	107	60	Cochrane	Cochrane	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	61	Collaboration	Collaboration	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	62	Skin	Skin	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	63	Group	Group	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	107	64	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	108	1	J	J	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	108	2	Am	Am	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	108	3	Acad	Acad	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	108	4	Dermatol	Dermatol	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	108	5	53:920–1	53:920–1	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	108	6	Crowley	Crowley	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	108	7	P	P	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	108	8	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	108	9	2000	2000	CD
work_4ezbiswdwvaltiifn3v3mawqzu	108	10	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	108	11	Prophylactic	prophylactic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	108	12	corticosteroids	corticosteroid	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	108	13	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	108	14	preterm	preterm	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	108	15	birth	birth	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	108	16	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	109	1	Cochrane	Cochrane	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	109	2	Database	Database	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	109	3	Syst	Syst	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	109	4	Rev	Rev	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	109	5	2	2	CD
work_4ezbiswdwvaltiifn3v3mawqzu	109	6	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	109	7	CD000065	cd000065	NN
work_4ezbiswdwvaltiifn3v3mawqzu	109	8	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	109	9	doi:10.1002/14651858	doi:10.1002/14651858	NN
work_4ezbiswdwvaltiifn3v3mawqzu	109	10	Egger	Egger	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	109	11	M	M	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	109	12	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	109	13	Smith	Smith	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	109	14	GD	GD	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	109	15	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	109	16	Altman	Altman	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	109	17	D	D	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	109	18	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	109	19	eds	eds	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	109	20	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	109	21	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	109	22	2001	2001	CD
work_4ezbiswdwvaltiifn3v3mawqzu	109	23	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	109	24	Systematic	Systematic	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	109	25	Reviews	Reviews	NNPS
work_4ezbiswdwvaltiifn3v3mawqzu	109	26	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	109	27	Health	Health	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	109	28	Care	Care	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	109	29	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	109	30	Meta	meta	NN
work_4ezbiswdwvaltiifn3v3mawqzu	109	31	-	-	HYPH
work_4ezbiswdwvaltiifn3v3mawqzu	109	32	analysis	analysis	NN
work_4ezbiswdwvaltiifn3v3mawqzu	109	33	on	on	IN
work_4ezbiswdwvaltiifn3v3mawqzu	109	34	Context	Context	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	109	35	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	110	1	BMJ	BMJ	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	110	2	Books	Books	NNPS
work_4ezbiswdwvaltiifn3v3mawqzu	110	3	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	110	4	London	London	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	110	5	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	110	6	p	p	NN
work_4ezbiswdwvaltiifn3v3mawqzu	110	7	4	4	CD
work_4ezbiswdwvaltiifn3v3mawqzu	110	8	Elwood	Elwood	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	110	9	JM	JM	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	110	10	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	110	11	Jopson	Jopson	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	110	12	J	J	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	110	13	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	110	14	1997	1997	CD
work_4ezbiswdwvaltiifn3v3mawqzu	110	15	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	110	16	Melanoma	Melanoma	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	110	17	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	110	18	sun	sun	NN
work_4ezbiswdwvaltiifn3v3mawqzu	110	19	exposure	exposure	NN
work_4ezbiswdwvaltiifn3v3mawqzu	110	20	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	110	21	an	an	DT
work_4ezbiswdwvaltiifn3v3mawqzu	110	22	overview	overview	NN
work_4ezbiswdwvaltiifn3v3mawqzu	110	23	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	110	24	published	publish	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	110	25	studies	study	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	110	26	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	111	1	Int	Int	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	111	2	J	J	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	111	3	Cancer	Cancer	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	111	4	73:198–203	73:198–203	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	111	5	Fergusson	Fergusson	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	111	6	D	D	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	111	7	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	111	8	Glass	Glass	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	111	9	K	K	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	111	10	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	111	11	Hutton	Hutton	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	111	12	B	B	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	111	13	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	111	14	Shapiro	Shapiro	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	111	15	S	S	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	111	16	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	111	17	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	111	18	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	111	19	Randomized	randomize	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	111	20	controlled	controlled	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	111	21	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	111	22	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	111	23	aprotinin	aprotinin	NN
work_4ezbiswdwvaltiifn3v3mawqzu	111	24	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	111	25	cardiac	cardiac	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	111	26	surgery	surgery	NN
work_4ezbiswdwvaltiifn3v3mawqzu	111	27	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	111	28	could	could	MD
work_4ezbiswdwvaltiifn3v3mawqzu	111	29	clinical	clinical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	111	30	equipoise	equipoise	NN
work_4ezbiswdwvaltiifn3v3mawqzu	111	31	have	have	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	111	32	stopped	stop	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	111	33	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	111	34	bleeding	bleeding	NN
work_4ezbiswdwvaltiifn3v3mawqzu	111	35	?	?	.
work_4ezbiswdwvaltiifn3v3mawqzu	112	1	Clin	Clin	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	112	2	Trials	Trials	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	112	3	2:218–32	2:218–32	CD
work_4ezbiswdwvaltiifn3v3mawqzu	112	4	Gallagher	Gallagher	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	112	5	RP	RP	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	112	6	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	112	7	Spinelli	Spinelli	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	112	8	JJ	JJ	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	112	9	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	112	10	Lee	Lee	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	112	11	TK	TK	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	112	12	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	112	13	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	112	14	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	112	15	Tanning	tanning	NN
work_4ezbiswdwvaltiifn3v3mawqzu	112	16	beds	bed	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	112	17	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	112	18	sunlamps	sunlamp	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	112	19	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	112	20	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	112	21	risk	risk	NN
work_4ezbiswdwvaltiifn3v3mawqzu	112	22	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	112	23	cutaneous	cutaneous	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	112	24	malignant	malignant	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	112	25	melanoma	melanoma	NN
work_4ezbiswdwvaltiifn3v3mawqzu	112	26	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	113	1	Cancer	Cancer	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	113	2	Epidemiol	Epidemiol	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	113	3	Biomarkers	Biomarkers	NNPS
work_4ezbiswdwvaltiifn3v3mawqzu	113	4	Prev	Prev	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	113	5	14:562–6	14:562–6	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	113	6	Gilbert	Gilbert	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	113	7	R	R	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	113	8	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	113	9	Salanti	Salanti	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	113	10	G	G	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	113	11	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	113	12	Harden	Harden	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	113	13	M	M	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	113	14	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	113	15	See	see	VB
work_4ezbiswdwvaltiifn3v3mawqzu	113	16	S	S	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	113	17	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	113	18	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	113	19	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	113	20	Infant	infant	NN
work_4ezbiswdwvaltiifn3v3mawqzu	113	21	sleeping	sleep	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	113	22	position	position	NN
work_4ezbiswdwvaltiifn3v3mawqzu	113	23	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	113	24	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	113	25	sudden	sudden	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	113	26	infant	infant	NN
work_4ezbiswdwvaltiifn3v3mawqzu	113	27	death	death	NN
work_4ezbiswdwvaltiifn3v3mawqzu	113	28	syndrome	syndrome	NN
work_4ezbiswdwvaltiifn3v3mawqzu	113	29	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	113	30	systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	113	31	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	113	32	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	113	33	observational	observational	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	113	34	studies	study	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	113	35	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	113	36	historical	historical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	113	37	review	review	NN
work_4ezbiswdwvaltiifn3v3mawqzu	113	38	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	113	39	recommendations	recommendation	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	113	40	from	from	IN
work_4ezbiswdwvaltiifn3v3mawqzu	113	41	1940	1940	CD
work_4ezbiswdwvaltiifn3v3mawqzu	113	42	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	113	43	2002	2002	CD
work_4ezbiswdwvaltiifn3v3mawqzu	113	44	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	114	1	Int	Int	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	114	2	J	J	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	114	3	Epidemiol	Epidemiol	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	114	4	34:874–87	34:874–87	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	114	5	Guyatt	Guyatt	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	114	6	GH	GH	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	114	7	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	114	8	Sackett	Sackett	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	114	9	DL	DL	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	114	10	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	114	11	Sinclair	Sinclair	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	114	12	JC	JC	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	114	13	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	114	14	Hayward	Hayward	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	114	15	R	R	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	114	16	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	114	17	Cook	Cook	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	114	18	DJ	DJ	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	114	19	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	114	20	Cook	Cook	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	114	21	RJ	RJ	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	114	22	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	114	23	1995	1995	CD
work_4ezbiswdwvaltiifn3v3mawqzu	114	24	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	114	25	User	User	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	114	26	’s	’s	POS
work_4ezbiswdwvaltiifn3v3mawqzu	114	27	guides	guide	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	114	28	to	to	IN
work_4ezbiswdwvaltiifn3v3mawqzu	114	29	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	114	30	medical	medical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	114	31	literature	literature	NN
work_4ezbiswdwvaltiifn3v3mawqzu	114	32	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	115	1	IX	ix	NN
work_4ezbiswdwvaltiifn3v3mawqzu	115	2	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	116	1	A	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	116	2	method	method	NN
work_4ezbiswdwvaltiifn3v3mawqzu	116	3	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	116	4	grading	grade	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	116	5	health	health	NN
work_4ezbiswdwvaltiifn3v3mawqzu	116	6	care	care	NN
work_4ezbiswdwvaltiifn3v3mawqzu	116	7	recommendations	recommendation	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	116	8	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	117	1	JAMA	JAMA	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	117	2	274:1800–4	274:1800–4	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	117	3	Ioannidis	Ioannidis	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	117	4	JP	JP	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	117	5	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	117	6	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	117	7	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	117	8	Contradicted	contradict	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	117	9	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	117	10	initially	initially	RB
work_4ezbiswdwvaltiifn3v3mawqzu	117	11	stronger	strong	JJR
work_4ezbiswdwvaltiifn3v3mawqzu	117	12	effects	effect	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	117	13	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	117	14	highly	highly	RB
work_4ezbiswdwvaltiifn3v3mawqzu	117	15	cited	cite	VBN
work_4ezbiswdwvaltiifn3v3mawqzu	117	16	clinical	clinical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	117	17	research	research	NN
work_4ezbiswdwvaltiifn3v3mawqzu	117	18	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	118	1	JAMA	JAMA	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	118	2	294:218–28	294:218–28	CD
work_4ezbiswdwvaltiifn3v3mawqzu	118	3	Johansen	Johansen	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	118	4	HK	HK	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	118	5	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	118	6	Moustgaard	Moustgaard	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	118	7	R	R	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	118	8	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	118	9	Gotzsche	Gotzsche	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	118	10	PC	PC	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	118	11	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	118	12	2001	2001	CD
work_4ezbiswdwvaltiifn3v3mawqzu	118	13	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	118	14	Anatomy	anatomy	NN
work_4ezbiswdwvaltiifn3v3mawqzu	118	15	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	118	16	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	118	17	Cochrane	Cochrane	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	118	18	Review	Review	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	118	19	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	119	1	9th	9th	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	119	2	International	International	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	119	3	Cochrane	Cochrane	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	119	4	Colloquium	Colloquium	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	119	5	;	;	:
work_4ezbiswdwvaltiifn3v3mawqzu	119	6	October	October	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	119	7	2001	2001	CD
work_4ezbiswdwvaltiifn3v3mawqzu	119	8	;	;	:
work_4ezbiswdwvaltiifn3v3mawqzu	119	9	Lyon	Lyon	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	119	10	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	119	11	France	France	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	119	12	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	120	1	Oral	oral	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	120	2	presentation	presentation	NN
work_4ezbiswdwvaltiifn3v3mawqzu	120	3	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	121	1	Cochrane	cochrane	NN
work_4ezbiswdwvaltiifn3v3mawqzu	121	2	1	1	CD
work_4ezbiswdwvaltiifn3v3mawqzu	121	3	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	121	4	op008	op008	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	121	5	Levin	Levin	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	121	6	A	A	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	121	7	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	121	8	2001	2001	CD
work_4ezbiswdwvaltiifn3v3mawqzu	121	9	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	121	10	The	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	121	11	Cochrane	Cochrane	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	121	12	Collaboration	Collaboration	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	121	13	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	122	1	Ann	Ann	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	122	2	Intern	Intern	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	122	3	Med	Med	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	122	4	135:309–12	135:309–12	CD
work_4ezbiswdwvaltiifn3v3mawqzu	122	5	Moher	Moher	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	122	6	D	D	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	122	7	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	122	8	Tsertsvadze	Tsertsvadze	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	122	9	A	A	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	122	10	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	122	11	2006	2006	CD
work_4ezbiswdwvaltiifn3v3mawqzu	122	12	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	122	13	Systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	122	14	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	122	15	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	122	16	when	when	WRB
work_4ezbiswdwvaltiifn3v3mawqzu	122	17	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	122	18	an	an	DT
work_4ezbiswdwvaltiifn3v3mawqzu	122	19	update	update	NN
work_4ezbiswdwvaltiifn3v3mawqzu	122	20	an	an	DT
work_4ezbiswdwvaltiifn3v3mawqzu	122	21	update	update	NN
work_4ezbiswdwvaltiifn3v3mawqzu	122	22	?	?	.
work_4ezbiswdwvaltiifn3v3mawqzu	123	1	Lancet	lancet	NN
work_4ezbiswdwvaltiifn3v3mawqzu	123	2	367:881–3	367:881–3	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	123	3	Morgan	Morgan	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	123	4	SG	SG	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	123	5	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	123	6	Bassett	Bassett	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	123	7	KL	KL	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	123	8	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	123	9	Wright	Wright	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	123	10	JM	JM	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	123	11	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	123	12	Evans	Evans	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	123	13	RG	RG	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	123	14	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	123	15	Barer	Barer	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	123	16	ML	ML	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	123	17	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	123	18	Caetano	Caetano	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	123	19	PA	PA	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	123	20	et	et	FW
work_4ezbiswdwvaltiifn3v3mawqzu	123	21	al	al	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	123	22	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	124	1	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	124	2	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	124	3	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	124	4	“	"	``
work_4ezbiswdwvaltiifn3v3mawqzu	124	5	Breakthrough	Breakthrough	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	124	6	”	"	''
work_4ezbiswdwvaltiifn3v3mawqzu	124	7	drugs	drug	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	124	8	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	124	9	growth	growth	NN
work_4ezbiswdwvaltiifn3v3mawqzu	124	10	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	124	11	expenditure	expenditure	NN
work_4ezbiswdwvaltiifn3v3mawqzu	124	12	on	on	IN
work_4ezbiswdwvaltiifn3v3mawqzu	124	13	prescription	prescription	NN
work_4ezbiswdwvaltiifn3v3mawqzu	124	14	drugs	drug	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	124	15	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	124	16	Canada	Canada	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	124	17	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	125	1	BMJ	BMJ	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	125	2	331:815–6	331:815–6	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	125	3	Moynihan	Moynihan	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	125	4	R	R	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	125	5	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	125	6	2004	2004	CD
work_4ezbiswdwvaltiifn3v3mawqzu	125	7	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	125	8	Evaluating	Evaluating	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	125	9	Health	Health	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	125	10	Services	Services	NNPS
work_4ezbiswdwvaltiifn3v3mawqzu	125	11	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	125	12	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	125	13	Reporter	reporter	NN
work_4ezbiswdwvaltiifn3v3mawqzu	125	14	Covers	cover	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	125	15	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	125	16	Science	Science	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	125	17	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	125	18	Research	Research	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	125	19	Synthesis	Synthesis	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	125	20	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	126	1	Milbank	Milbank	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	126	2	Memorial	Memorial	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	126	3	Fund	Fund	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	126	4	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	126	5	New	New	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	126	6	York	York	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	126	7	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	127	1	Available	available	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	127	2	at	at	IN
work_4ezbiswdwvaltiifn3v3mawqzu	127	3	http://www.milbank.org/reports/2004Moynihan/040330Moynihan.html	http://www.milbank.org/reports/2004moynihan/040330moynihan.html	NN
work_4ezbiswdwvaltiifn3v3mawqzu	127	4	Parker	Parker	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	127	5	ER	ER	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	127	6	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	127	7	Schilling	Schilling	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	127	8	LM	LM	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	127	9	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	127	10	Diba	Diba	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	127	11	V	V	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	127	12	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	127	13	Williams	Williams	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	127	14	HC	HC	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	127	15	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	127	16	Dellavalle	Dellavalle	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	127	17	RP	RP	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	127	18	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	127	19	2004	2004	CD
work_4ezbiswdwvaltiifn3v3mawqzu	127	20	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	127	21	What	what	WP
work_4ezbiswdwvaltiifn3v3mawqzu	127	22	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	127	23	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	127	24	point	point	NN
work_4ezbiswdwvaltiifn3v3mawqzu	127	25	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	127	26	databases	database	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	127	27	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	127	28	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	127	29	for	for	IN
work_4ezbiswdwvaltiifn3v3mawqzu	127	30	dermatology	dermatology	NN
work_4ezbiswdwvaltiifn3v3mawqzu	127	31	if	if	IN
work_4ezbiswdwvaltiifn3v3mawqzu	127	32	all	all	DT
work_4ezbiswdwvaltiifn3v3mawqzu	127	33	they	-PRON-	PRP
work_4ezbiswdwvaltiifn3v3mawqzu	127	34	compile	compile	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	127	35	is	be	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	127	36	“	"	``
work_4ezbiswdwvaltiifn3v3mawqzu	127	37	insufficient	insufficient	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	127	38	evidence	evidence	NN
work_4ezbiswdwvaltiifn3v3mawqzu	127	39	”	"	''
work_4ezbiswdwvaltiifn3v3mawqzu	127	40	?	?	.
work_4ezbiswdwvaltiifn3v3mawqzu	128	1	J	J	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	128	2	Am	Am	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	128	3	Acad	Acad	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	128	4	Dermatol	Dermatol	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	128	5	50:635–9	50:635–9	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	128	6	Patsopoulos	Patsopoulos	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	128	7	NA	NA	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	128	8	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	128	9	Analatos	Analatos	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	128	10	AA	AA	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	128	11	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	128	12	Ioannidis	Ioannidis	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	128	13	JP	JP	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	128	14	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	128	15	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	128	16	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	128	17	Relative	relative	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	128	18	citation	citation	NN
work_4ezbiswdwvaltiifn3v3mawqzu	128	19	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	128	20	various	various	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	128	21	study	study	NN
work_4ezbiswdwvaltiifn3v3mawqzu	128	22	designs	design	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	128	23	in	in	IN
work_4ezbiswdwvaltiifn3v3mawqzu	128	24	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	128	25	health	health	NN
work_4ezbiswdwvaltiifn3v3mawqzu	128	26	sciences	science	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	128	27	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	129	1	JAMA	JAMA	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	129	2	293:2362–6	293:2362–6	CD
work_4ezbiswdwvaltiifn3v3mawqzu	129	3	Smith	Smith	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	129	4	R	R	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	129	5	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	129	6	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	129	7	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	129	8	Medical	medical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	129	9	journals	journal	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	129	10	are	be	VBP
work_4ezbiswdwvaltiifn3v3mawqzu	129	11	an	an	DT
work_4ezbiswdwvaltiifn3v3mawqzu	129	12	extension	extension	NN
work_4ezbiswdwvaltiifn3v3mawqzu	129	13	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	129	14	the	the	DT
work_4ezbiswdwvaltiifn3v3mawqzu	129	15	marketing	marketing	NN
work_4ezbiswdwvaltiifn3v3mawqzu	129	16	arm	arm	NN
work_4ezbiswdwvaltiifn3v3mawqzu	129	17	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	129	18	pharmaceutical	pharmaceutical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	129	19	companies	company	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	129	20	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	130	1	PLoS	plos	ADD
work_4ezbiswdwvaltiifn3v3mawqzu	130	2	Med	Med	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	130	3	2	2	CD
work_4ezbiswdwvaltiifn3v3mawqzu	130	4	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	130	5	e138	e138	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	130	6	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	130	7	doi:10.1371	doi:10.1371	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	130	8	/	/	SYM
work_4ezbiswdwvaltiifn3v3mawqzu	130	9	journal	journal	NN
work_4ezbiswdwvaltiifn3v3mawqzu	130	10	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	131	1	pmed.0020138	pmed.0020138	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	131	2	Smith	Smith	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	131	3	R	R	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	131	4	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	131	5	Roberts	Roberts	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	131	6	I	-PRON-	PRP
work_4ezbiswdwvaltiifn3v3mawqzu	131	7	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	131	8	2006	2006	CD
work_4ezbiswdwvaltiifn3v3mawqzu	131	9	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	131	10	Patient	patient	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	131	11	safety	safety	NN
work_4ezbiswdwvaltiifn3v3mawqzu	131	12	requires	require	VBZ
work_4ezbiswdwvaltiifn3v3mawqzu	131	13	a	a	DT
work_4ezbiswdwvaltiifn3v3mawqzu	131	14	new	new	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	131	15	way	way	NN
work_4ezbiswdwvaltiifn3v3mawqzu	131	16	to	to	TO
work_4ezbiswdwvaltiifn3v3mawqzu	131	17	publish	publish	VB
work_4ezbiswdwvaltiifn3v3mawqzu	131	18	clinical	clinical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	131	19	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	131	20	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	132	1	PLoS	PLoS	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	2	Clinical	Clinical	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	3	Trials	Trials	NNPS
work_4ezbiswdwvaltiifn3v3mawqzu	132	4	1	1	CD
work_4ezbiswdwvaltiifn3v3mawqzu	132	5	:	:	:
work_4ezbiswdwvaltiifn3v3mawqzu	132	6	e6	e6	NN
work_4ezbiswdwvaltiifn3v3mawqzu	132	7	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	132	8	doi:10.1371	doi:10.1371	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	9	/	/	SYM
work_4ezbiswdwvaltiifn3v3mawqzu	132	10	journal.pctr.0010006	journal.pctr.0010006	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	11	Tugwell	Tugwell	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	12	P	P	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	13	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	132	14	Petticrew	Petticrew	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	15	M	M	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	16	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	132	17	Robinson	Robinson	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	18	V	V	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	19	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	132	20	Kristjansson	Kristjansson	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	21	E	E	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	22	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	132	23	Maxwell	Maxwell	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	24	L	L	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	25	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	132	26	Cochrane	Cochrane	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	27	Equity	Equity	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	28	Field	Field	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	29	Editorial	Editorial	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	30	Team	Team	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	31	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	132	32	2006a	2006a	LS
work_4ezbiswdwvaltiifn3v3mawqzu	132	33	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	132	34	Cochrane	Cochrane	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	35	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	132	36	Campbell	Campbell	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	132	37	Collaborations	Collaborations	NNPS
work_4ezbiswdwvaltiifn3v3mawqzu	132	38	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	132	39	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	132	40	health	health	NN
work_4ezbiswdwvaltiifn3v3mawqzu	132	41	equity	equity	NN
work_4ezbiswdwvaltiifn3v3mawqzu	132	42	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	133	1	Lancet	Lancet	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	133	2	367:1128–30	367:1128–30	CD
work_4ezbiswdwvaltiifn3v3mawqzu	133	3	Tugwell	Tugwell	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	133	4	P	P	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	133	5	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	133	6	Robinson	Robinson	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	133	7	V	V	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	133	8	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	133	9	Grimshaw	Grimshaw	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	133	10	J	J	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	133	11	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	133	12	Santesso	Santesso	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	133	13	N	N	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	133	14	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	133	15	2006b	2006b	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	133	16	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	133	17	Systematic	systematic	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	133	18	reviews	review	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	133	19	and	and	CC
work_4ezbiswdwvaltiifn3v3mawqzu	133	20	knowledge	knowledge	NN
work_4ezbiswdwvaltiifn3v3mawqzu	133	21	translation	translation	NN
work_4ezbiswdwvaltiifn3v3mawqzu	133	22	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	134	1	Bull	Bull	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	134	2	World	World	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	134	3	Health	Health	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	134	4	Organ	Organ	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	134	5	84:643–51	84:643–51	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	134	6	Williams	Williams	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	134	7	HC	HC	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	134	8	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	134	9	Stern	Stern	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	134	10	RS	RS	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	134	11	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	134	12	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	134	13	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	134	14	Prospective	Prospective	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	134	15	Clinical	Clinical	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	134	16	Trial	Trial	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	134	17	Registration	Registration	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	134	18	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	135	1	Journal	Journal	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	135	2	of	of	IN
work_4ezbiswdwvaltiifn3v3mawqzu	135	3	Investigative	Investigative	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	135	4	Dermatology	Dermatology	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	135	5	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	135	6	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	135	7	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	135	8	124	124	CD
work_4ezbiswdwvaltiifn3v3mawqzu	135	9	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	135	10	viii	viii	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	135	11	–	–	:
work_4ezbiswdwvaltiifn3v3mawqzu	135	12	x	x	LS
work_4ezbiswdwvaltiifn3v3mawqzu	135	13	;	;	:
work_4ezbiswdwvaltiifn3v3mawqzu	135	14	doi:10.1111	doi:10.1111	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	135	15	/	/	SYM
work_4ezbiswdwvaltiifn3v3mawqzu	135	16	j.0022	j.0022	NN
work_4ezbiswdwvaltiifn3v3mawqzu	135	17	–	–	:
work_4ezbiswdwvaltiifn3v3mawqzu	135	18	202X.2005.23665.x	202x.2005.23665.x	CD
work_4ezbiswdwvaltiifn3v3mawqzu	135	19	Young	young	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	135	20	C	C	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	135	21	,	,	,
work_4ezbiswdwvaltiifn3v3mawqzu	135	22	Horton	Horton	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	135	23	R	R	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	135	24	(	(	-LRB-
work_4ezbiswdwvaltiifn3v3mawqzu	135	25	2005	2005	CD
work_4ezbiswdwvaltiifn3v3mawqzu	135	26	)	)	-RRB-
work_4ezbiswdwvaltiifn3v3mawqzu	135	27	Putting	put	VBG
work_4ezbiswdwvaltiifn3v3mawqzu	135	28	clinical	clinical	JJ
work_4ezbiswdwvaltiifn3v3mawqzu	135	29	trials	trial	NNS
work_4ezbiswdwvaltiifn3v3mawqzu	135	30	into	into	IN
work_4ezbiswdwvaltiifn3v3mawqzu	135	31	context	context	NN
work_4ezbiswdwvaltiifn3v3mawqzu	135	32	.	.	.
work_4ezbiswdwvaltiifn3v3mawqzu	136	1	Lancet	Lancet	NNP
work_4ezbiswdwvaltiifn3v3mawqzu	136	2	366:107–8	366:107–8	CD
work_4ezbiswdwvaltiifn3v3mawqzu	136	3	EDITORIAL	editorial	NN